false 2022 Q3 0001567925 true 12/31 0001567925 2022-01-01 2022-09-30 0001567925 us-gaap:CommonClassAMember 2022-11-04 xbrli:shares 0001567925 cik0001567925:CommonClassIMember 2022-11-04 0001567925 cik0001567925:CommonClassTMember 2022-11-04 0001567925 cik0001567925:CommonClassT2Member 2022-11-04 0001567925 2022-09-30 iso4217:USD 0001567925 2021-12-31 iso4217:USD xbrli:shares 0001567925 2022-07-01 2022-09-30 0001567925 2021-07-01 2021-09-30 0001567925 2021-01-01 2021-09-30 0001567925 us-gaap:CommonStockMember 2022-06-30 0001567925 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001567925 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2022-06-30 0001567925 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001567925 us-gaap:ParentMember 2022-06-30 0001567925 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001567925 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001567925 us-gaap:ParentMember 2022-07-01 2022-09-30 0001567925 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2022-07-01 2022-09-30 0001567925 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0001567925 us-gaap:CommonStockMember 2022-09-30 0001567925 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001567925 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2022-09-30 0001567925 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001567925 us-gaap:ParentMember 2022-09-30 0001567925 us-gaap:CommonStockMember 2021-12-31 0001567925 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001567925 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2021-12-31 0001567925 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001567925 us-gaap:ParentMember 2021-12-31 0001567925 us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001567925 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-09-30 0001567925 us-gaap:ParentMember 2022-01-01 2022-09-30 0001567925 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2022-01-01 2022-09-30 0001567925 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-09-30 0001567925 us-gaap:CommonStockMember 2021-06-30 0001567925 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001567925 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2021-06-30 0001567925 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001567925 us-gaap:ParentMember 2021-06-30 0001567925 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001567925 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001567925 us-gaap:ParentMember 2021-07-01 2021-09-30 0001567925 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2021-07-01 2021-09-30 0001567925 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0001567925 us-gaap:CommonStockMember 2021-09-30 0001567925 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001567925 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2021-09-30 0001567925 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001567925 us-gaap:ParentMember 2021-09-30 0001567925 us-gaap:CommonStockMember 2020-12-31 0001567925 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001567925 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2020-12-31 0001567925 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001567925 us-gaap:ParentMember 2020-12-31 0001567925 us-gaap:CommonStockMember 2021-01-01 2021-09-30 0001567925 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-09-30 0001567925 us-gaap:ParentMember 2021-01-01 2021-09-30 0001567925 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2021-01-01 2021-09-30 0001567925 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-09-30 0001567925 2020-12-31 0001567925 2021-09-30 0001567925 cik0001567925:DataCentersMember us-gaap:DiscontinuedOperationsHeldforsaleMember 2021-05-19 cik0001567925:property 0001567925 cik0001567925:DataCentersMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2021-07-22 0001567925 cik0001567925:DataCentersMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2021-07-22 2021-07-22 0001567925 2021-07-22 0001567925 2021-07-30 2021-07-30 cik0001567925:transaction 0001567925 cik0001567925:YukonHealthcareFacilityMember 2022-03-10 xbrli:pure 0001567925 cik0001567925:YukonHealthcareFacilityMember 2022-03-10 2022-03-10 0001567925 cik0001567925:PleasantHillsHealthcareFacilityMember 2022-05-12 0001567925 cik0001567925:PleasantHillsHealthcareFacilityMember 2022-05-12 2022-05-12 0001567925 cik0001567925:ProsserHealthcareFacilitiesMember 2022-05-20 0001567925 cik0001567925:ProsserHealthcareFacilitiesMember 2022-05-20 2022-05-20 0001567925 cik0001567925:TampaHealthcareFacilityIIMember 2022-07-20 0001567925 cik0001567925:TampaHealthcareFacilityIIMember 2022-07-20 2022-07-20 0001567925 cik0001567925:EscondidoHealthcareFacilityMember 2022-07-21 0001567925 cik0001567925:EscondidoHealthcareFacilityMember 2022-07-21 2022-07-21 0001567925 us-gaap:LandMember cik0001567925:A2022AcquisitionMember 2022-01-01 2022-09-30 0001567925 us-gaap:BuildingAndBuildingImprovementsMember cik0001567925:A2022AcquisitionMember 2022-01-01 2022-09-30 0001567925 cik0001567925:TenantImprovementsMember cik0001567925:A2022AcquisitionMember 2022-01-01 2022-09-30 0001567925 us-gaap:LeasesAcquiredInPlaceMember cik0001567925:A2022AcquisitionMember 2022-01-01 2022-09-30 0001567925 us-gaap:AboveMarketLeasesMember cik0001567925:A2022AcquisitionMember 2022-01-01 2022-09-30 0001567925 cik0001567925:A2022AcquisitionMember 2022-01-01 2022-09-30 0001567925 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember cik0001567925:A2022DispositionMember 2022-02-10 2022-02-10 0001567925 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember cik0001567925:A2022DispositionMember 2022-02-10 0001567925 us-gaap:GeographicConcentrationRiskMember us-gaap:SalesRevenueNetMember 2022-09-30 cik0001567925:statisticalArea 0001567925 cik0001567925:HoustonTheWoodlandsSugarLandTexasMSAMember us-gaap:GeographicConcentrationRiskMember us-gaap:SalesRevenueNetMember 2022-01-01 2022-09-30 0001567925 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2022-09-30 cik0001567925:tenant 0001567925 us-gaap:CustomerConcentrationRiskMember cik0001567925:PostAcuteMedicalLLCAndAffiliatesMember us-gaap:SalesRevenueNetMember 2022-01-01 2022-09-30 0001567925 us-gaap:LeasesAcquiredInPlaceMember 2022-01-01 2022-09-30 cik0001567925:lease 0001567925 cik0001567925:HealthcareFacilitiesMember us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember 2021-12-31 cik0001567925:numberOfLandParcel 0001567925 us-gaap:LeasesAcquiredInPlaceMember 2021-01-01 2021-09-30 0001567925 cik0001567925:TenantOfHealthcarePropertyMember 2021-01-01 2021-09-30 0001567925 us-gaap:LandMember us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember 2021-12-31 0001567925 us-gaap:BuildingAndBuildingImprovementsMember us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember 2021-12-31 0001567925 us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember 2021-12-31 0001567925 cik0001567925:DataCentersMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2021-07-01 2021-09-30 0001567925 cik0001567925:DataCentersMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2021-01-01 2021-09-30 0001567925 us-gaap:SegmentContinuingOperationsMember cik0001567925:DataCentersMember cik0001567925:HealthcareFacilitiesMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2021-07-22 0001567925 cik0001567925:DataCentersMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2021-04-01 2021-06-30 0001567925 cik0001567925:DataCentersMember us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember 2021-01-01 2021-09-30 0001567925 us-gaap:LeasesAcquiredInPlaceMember 2022-09-30 0001567925 us-gaap:LeasesAcquiredInPlaceMember 2021-12-31 0001567925 us-gaap:LeasesAcquiredInPlaceMember 2021-01-01 2021-12-31 0001567925 us-gaap:AboveMarketLeasesMember 2022-09-30 0001567925 us-gaap:AboveMarketLeasesMember 2021-12-31 0001567925 us-gaap:AboveMarketLeasesMember 2022-01-01 2022-09-30 0001567925 us-gaap:AboveMarketLeasesMember 2021-01-01 2021-12-31 0001567925 2021-01-01 2021-12-31 0001567925 srt:MinimumMember 2022-09-30 0001567925 srt:MaximumMember 2022-09-30 0001567925 us-gaap:CostOfSalesMember 2022-07-01 2022-09-30 0001567925 us-gaap:CostOfSalesMember 2021-07-01 2021-09-30 0001567925 us-gaap:CostOfSalesMember 2022-01-01 2022-09-30 0001567925 us-gaap:CostOfSalesMember 2021-01-01 2021-09-30 0001567925 cik0001567925:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToParentMember 2022-07-01 2022-09-30 0001567925 cik0001567925:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToParentMember 2021-07-01 2021-09-30 0001567925 cik0001567925:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToParentMember 2022-01-01 2022-09-30 0001567925 cik0001567925:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToParentMember 2021-01-01 2021-09-30 0001567925 us-gaap:GeneralAndAdministrativeExpenseMember 2022-07-01 2022-09-30 0001567925 us-gaap:GeneralAndAdministrativeExpenseMember 2021-07-01 2021-09-30 0001567925 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-09-30 0001567925 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-09-30 0001567925 cik0001567925:DepreciationDepletionAndAmortizationNonproductionMember 2022-07-01 2022-09-30 0001567925 cik0001567925:DepreciationDepletionAndAmortizationNonproductionMember 2021-07-01 2021-09-30 0001567925 cik0001567925:DepreciationDepletionAndAmortizationNonproductionMember 2022-01-01 2022-09-30 0001567925 cik0001567925:DepreciationDepletionAndAmortizationNonproductionMember 2021-01-01 2021-09-30 0001567925 cik0001567925:InterestIncomeExpenseNonoperatingNetMember 2022-07-01 2022-09-30 0001567925 cik0001567925:InterestIncomeExpenseNonoperatingNetMember 2021-07-01 2021-09-30 0001567925 cik0001567925:InterestIncomeExpenseNonoperatingNetMember 2022-01-01 2022-09-30 0001567925 cik0001567925:InterestIncomeExpenseNonoperatingNetMember 2021-01-01 2021-09-30 0001567925 cik0001567925:VariableRateLineOfCreditMember us-gaap:RevolvingCreditFacilityMember 2022-09-30 0001567925 cik0001567925:VariableRateLineOfCreditMember us-gaap:RevolvingCreditFacilityMember 2021-12-31 0001567925 us-gaap:UnsecuredDebtMember cik0001567925:VariableRateTermLoanSubjectToInterestRateSwapMember 2022-09-30 0001567925 us-gaap:UnsecuredDebtMember cik0001567925:VariableRateTermLoanSubjectToInterestRateSwapMember 2021-12-31 0001567925 us-gaap:UnsecuredDebtMember cik0001567925:VariableRateTermLoanMember 2022-09-30 0001567925 us-gaap:UnsecuredDebtMember cik0001567925:VariableRateTermLoanMember 2021-12-31 0001567925 cik0001567925:VariableRateLineOfCreditMember us-gaap:RevolvingCreditFacilityMember 2022-02-15 0001567925 us-gaap:RevolvingCreditFacilityMember us-gaap:UnsecuredDebtMember 2022-02-15 0001567925 cik0001567925:VariableRateLineOfCreditMember us-gaap:RevolvingCreditFacilityMember 2022-02-14 0001567925 cik0001567925:TermLoanMember us-gaap:UnsecuredDebtMember 2022-02-15 0001567925 us-gaap:RevolvingCreditFacilityMember 2022-01-01 2022-09-30 0001567925 us-gaap:InterestRateSwapMember 2022-04-08 cik0001567925:agreement 0001567925 cik0001567925:InterestRateSwapEffectiveDateMay22022Member 2022-04-08 0001567925 cik0001567925:InterestRateSwapEffectiveDateMay12023Member 2022-04-08 0001567925 cik0001567925:A2028TermLoanMember us-gaap:UnsecuredDebtMember 2022-05-17 0001567925 cik0001567925:A2028TermLoanMember us-gaap:UnsecuredDebtMember 2022-05-17 2022-05-17 0001567925 2022-05-17 0001567925 cik0001567925:UnsecuredCreditFacilityMember us-gaap:UnsecuredDebtMember 2022-09-30 0001567925 cik0001567925:A2028TermLoanMember us-gaap:BaseRateMember srt:MinimumMember us-gaap:UnsecuredDebtMember 2022-05-17 2022-05-17 0001567925 cik0001567925:A2028TermLoanMember srt:MaximumMember us-gaap:BaseRateMember us-gaap:UnsecuredDebtMember 2022-05-17 2022-05-17 0001567925 cik0001567925:A2028TermLoanMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember srt:MinimumMember us-gaap:UnsecuredDebtMember 2022-05-17 2022-05-17 0001567925 cik0001567925:A2028TermLoanMember srt:MaximumMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember us-gaap:UnsecuredDebtMember 2022-05-17 2022-05-17 0001567925 cik0001567925:A2028TermLoanMember us-gaap:UnsecuredDebtMember 2022-07-12 2022-07-12 0001567925 cik0001567925:A2028TermLoanMember us-gaap:UnsecuredDebtMember 2022-07-20 2022-07-20 0001567925 cik0001567925:VariableRateLineOfCreditMember us-gaap:RevolvingCreditFacilityMember 2022-01-01 2022-09-30 0001567925 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001567925 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2022-09-30 0001567925 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001567925 us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001567925 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001567925 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001567925 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001567925 us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001567925 us-gaap:SegmentContinuingOperationsMember cik0001567925:DataCentersMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember us-gaap:InterestRateSwapMember 2021-07-22 cik0001567925:interestRateSwapInstrument 0001567925 us-gaap:SegmentContinuingOperationsMember cik0001567925:DataCentersMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2022-07-01 2022-09-30 0001567925 us-gaap:SegmentContinuingOperationsMember cik0001567925:DataCentersMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2022-01-01 2022-09-30 0001567925 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-09-30 0001567925 us-gaap:OtherAssetsMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-09-30 0001567925 us-gaap:AccountsPayableMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-09-30 0001567925 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0001567925 us-gaap:OtherAssetsMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0001567925 us-gaap:AccountsPayableMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0001567925 cik0001567925:InterestRateSwapMaturityDateApril272023Member 2022-04-08 0001567925 us-gaap:SegmentContinuingOperationsMember us-gaap:InterestRateSwapMember 2022-07-01 2022-09-30 0001567925 us-gaap:SegmentContinuingOperationsMember us-gaap:InterestExpenseMember us-gaap:InterestRateSwapMember 2022-07-01 2022-09-30 0001567925 us-gaap:SegmentContinuingOperationsMember 2022-07-01 2022-09-30 0001567925 us-gaap:SegmentContinuingOperationsMember us-gaap:InterestRateSwapMember 2021-07-01 2021-09-30 0001567925 us-gaap:SegmentContinuingOperationsMember us-gaap:InterestExpenseMember us-gaap:InterestRateSwapMember 2021-07-01 2021-09-30 0001567925 us-gaap:SegmentContinuingOperationsMember 2021-07-01 2021-09-30 0001567925 cik0001567925:DataCentersMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember us-gaap:InterestRateSwapMember 2021-07-01 2021-09-30 0001567925 cik0001567925:DataCentersMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember cik0001567925:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToParentMember us-gaap:InterestRateSwapMember 2021-07-01 2021-09-30 0001567925 us-gaap:SegmentContinuingOperationsMember us-gaap:InterestRateSwapMember 2022-01-01 2022-09-30 0001567925 us-gaap:SegmentContinuingOperationsMember us-gaap:InterestExpenseMember us-gaap:InterestRateSwapMember 2022-01-01 2022-09-30 0001567925 us-gaap:SegmentContinuingOperationsMember 2022-01-01 2022-09-30 0001567925 us-gaap:SegmentContinuingOperationsMember us-gaap:InterestRateSwapMember 2021-01-01 2021-09-30 0001567925 us-gaap:SegmentContinuingOperationsMember us-gaap:InterestExpenseMember us-gaap:InterestRateSwapMember 2021-01-01 2021-09-30 0001567925 us-gaap:SegmentContinuingOperationsMember 2021-01-01 2021-09-30 0001567925 cik0001567925:DataCentersMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember us-gaap:InterestRateSwapMember 2021-01-01 2021-09-30 0001567925 cik0001567925:DataCentersMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember cik0001567925:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToParentMember us-gaap:InterestRateSwapMember 2021-01-01 2021-09-30 0001567925 us-gaap:CommonStockMember cik0001567925:ClassAIAndTSharesMember 2022-01-01 2022-09-30 0001567925 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001567925 cik0001567925:CommonClassIMember us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001567925 cik0001567925:CommonClassTMember us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001567925 us-gaap:CommonStockMember cik0001567925:ClassAIAndTSharesMember 2021-01-01 2021-09-30 0001567925 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-01-01 2021-09-30 0001567925 cik0001567925:CommonClassIMember us-gaap:CommonStockMember 2021-01-01 2021-09-30 0001567925 cik0001567925:CommonClassTMember us-gaap:CommonStockMember 2021-01-01 2021-09-30 0001567925 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-12-31 0001567925 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-01-01 2022-09-30 0001567925 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-09-30 0001567925 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-12-31 0001567925 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-01-01 2021-09-30 0001567925 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-09-30 0001567925 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:InterestRateSwapMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-01-01 2022-09-30 0001567925 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:InterestRateSwapMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-01-01 2021-09-30 0001567925 cik0001567925:RestrictedStockTimeBasedMember 2022-01-03 2022-01-03 0001567925 cik0001567925:RestrictedStockTimeBasedAndPerformanceBasedMember 2022-07-01 2022-09-30 0001567925 cik0001567925:RestrictedStockTimeBasedAndPerformanceBasedMember 2022-01-01 2022-09-30 cik0001567925:legalProceeding 0001567925 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2022-10-06 2022-10-06 0001567925 cik0001567925:CommonClassIMember us-gaap:SubsequentEventMember 2022-10-06 2022-10-06 0001567925 cik0001567925:CommonClassTMember us-gaap:SubsequentEventMember 2022-10-06 2022-10-06 0001567925 us-gaap:SubsequentEventMember 2022-10-06 2022-10-06 0001567925 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2022-11-04 2022-11-04 0001567925 cik0001567925:CommonClassIMember us-gaap:SubsequentEventMember 2022-11-04 2022-11-04 0001567925 cik0001567925:CommonClassTMember us-gaap:SubsequentEventMember 2022-11-04 2022-11-04 0001567925 us-gaap:SubsequentEventMember 2022-11-04 2022-11-04 0001567925 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2022-10-20 2022-10-20 0001567925 cik0001567925:CommonClassIMember us-gaap:SubsequentEventMember 2022-10-20 2022-10-20 0001567925 cik0001567925:CommonClassTMember us-gaap:SubsequentEventMember 2022-10-20 2022-10-20 0001567925 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2022-11-08 2022-11-08 0001567925 cik0001567925:CommonClassIMember us-gaap:SubsequentEventMember 2022-11-08 2022-11-08 0001567925 cik0001567925:CommonClassTMember us-gaap:SubsequentEventMember 2022-11-08 2022-11-08 0001567925 cik0001567925:CommonClassAIAndTSharesMember us-gaap:SubsequentEventMember 2022-10-20 2022-10-20 0001567925 cik0001567925:CommonClassAIAndTSharesMember us-gaap:SubsequentEventMember 2022-11-08 2022-11-08

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________________
FORM 10-Q
(Mark One)

☒ |  | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2022
OR

☐ |  | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to
Commission File Number: 000-55435
SILA REALTY TRUST, INC.
(Exact name of registrant as specified in its charter)

Maryland |  | 46-1854011
(State or Other Jurisdiction of Incorporation or Organization) |  | (I.R.S. Employer Identification No.)
1001 Water Street, Suite 800 Tampa, FL 33602 |  | (813)-287-0101
(Address of Principal Executive Offices; Zip Code) |  | (Registrant’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act: None

Title of each class |  | Trading Symbol |  | Name of each exchange on which registered
N/A |  | N/A |  | N/A

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer |  | ☐ |  | Accelerated filer |  | ☐
Non-accelerated filer |  | ☒ |  | Smaller reporting company |  | ☐
|  |  |  | Emerging growth company |  | ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of November 4, 2022, there were approximately 168,298,000 shares of Class A common stock, 16,717,000 shares of Class I common stock, 40,990,000 shares of Class T common stock and 0 shares of Class T2 common stock of Sila Realty Trust, Inc. outstanding.

SILA REALTY TRUST, INC.
(A Maryland Corporation)
TABLE OF CONTENTS

|  | Page
PART I. | FINANCIAL INFORMATION (Unaudited) | 3
Item 1. | Condensed Consolidated Financial Statements | 3
| Condensed Consolidated Balance Sheets as of September 30, 2022 and December 31, 2021 | 3
| Condensed Consolidated Statements of Comprehensive Income for the Three and Nine Months Ended September 30, 2022 and 2021 | 4
| Condensed Consolidated Statements of Equity for the Three and Nine Months Ended Se ptember 30, 2022 and 2021 | 5
| Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2022 and 2021 | 7
| Notes to the Condensed Consolidated Financial Statements | 8
Item 2. | Management's Discussion and Analysis of Financial Condition and Results of Operations | 23
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 34
Item 4. | Controls and Procedures | 35
PART II. | OTHER INFORMATION | 36
Item 1. | Legal Proceedings | 36
Item 1A. | Risk Factors | 36
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 36
Item 3. | Defaults Upon Senior Securities | 36
Item 4. | Mine Safety Disclosures | 36
Item 5. | Other Information | 36
Item 6. | Exhibits | 37
SIGNATURES |

Table of Contents
PART I. FINANCIAL INFORMATION
Item 1. Condensed Consolidated Financial Statements.
SILA REALTY TRUST, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share data)

| (Unaudited) September 30, 2022 |  | December 31, 2021
ASSETS
Real estate: |  |  |
Land | $ | 166,037 |  |  | $ | 163,992 |
Buildings and improvements, less accumulated depreciation of $199,236 and $165,784, respectively | 1,764,835 |  |  | 1,648,685 |
Construction in progress | — |  |  | 14,628 |
Total real estate, net | 1,930,872 |  |  | 1,827,305 |
Cash and cash equivalents | 17,291 |  |  | 32,359 |
Acquired intangible assets, less accumulated amortization of $85,888 and $71,067, respectively | 177,315 |  |  | 181,639 |
Goodwill | 23,006 |  |  | 23,284 |
Right-of-use assets | 38,580 |  |  | 24,033 |
Other assets, net | 102,745 |  |  | 66,365 |
Assets held for sale | — |  |  | 22,570 |
Total assets | $ | 2,289,809 |  |  | $ | 2,177,555 |
LIABILITIES AND STOCKHOLDERS’ EQUITY
Liabilities: |  |  |
Credit facility, net of deferred financing costs of $2,570 and $3,226, respectively | 597,430 |  |  | 496,774 |
Accounts payable and other liabilities | 28,579 |  |  | 39,597 |
Acquired intangible liabilities, less accumulated amortization of $5,550 and $4,444, respectively | 12,319 |  |  | 12,962 |
Lease liabilities | 41,640 |  |  | 26,394 |
Liabilities held for sale | — |  |  | 698 |
Total liabilities | 679,968 |  |  | 576,425 |
Stockholders’ equity: |  |  |
Preferred stock, $0.01 par value per share, 100,000,000 shares authorized; none issued and outstanding | — |  |  | — |
Common stock, $0.01 par value per share, 510,000,000 shares authorized; 240,666,572 and 238,226,119 shares issued, respectively; 225,833,531 and 224,179,939 shares outstanding, respectively | 2,258 |  |  | 2,242 |
Additional paid-in capital | 2,019,564 |  |  | 2,004,404 |
Distributions in excess of accumulated earnings | (441,591) |  |  | (400,669) |
Accumulated other comprehensive income (loss) | 29,610 |  |  | (4,847) |
Total stockholders’ equity | 1,609,841 |  |  | 1,601,130 |
Total liabilities and stockholders’ equity | $ | 2,289,809 |  |  | $ | 2,177,555 |

The accompanying notes are an integral part of these condensed consolidated financial statements.
3

Table of Contents
SILA REALTY TRUST, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in thousands, except share data and per share amounts)
(Unaudited)

| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2022 |  | 2021 |  | 2022 |  | 2021 |  |
Revenue: |  |  |  |  |  |  |  |  |
Rental revenue | $ | 46,881 |  |  | $ | 43,063 |  |  | $ | 136,081 |  |  | $ | 129,232 |  |  |
Expenses: |  |  |  |  |  |  |  |  |
Rental expenses | 3,232 |  |  | 3,024 |  |  | 9,267 |  |  | 9,513 |  |  |
General and administrative expenses | 6,118 |  |  | 6,348 |  |  | 20,718 |  |  | 19,610 |  |  |
Depreciation and amortization | 18,641 |  |  | 17,259 |  |  | 54,443 |  |  | 53,098 |  |  |
Impairment losses | — |  |  | 10,241 |  |  | 7,387 |  |  | 27,837 |  |  |
Total expenses | 27,991 |  |  | 36,872 |  |  | 91,815 |  |  | 110,058 |  |  |
Gain on real estate disposition | — |  |  | — |  |  | 460 |  |  | — |  |  |
Interest and other expense, net | 5,498 |  |  | 11,737 |  |  | 17,942 |  |  | 30,035 |  |  |
Income (loss) from continuing operations | 13,392 |  |  | (5,546) |  |  | 26,784 |  |  | (10,861) |  |  |
Income from discontinued operations | — |  |  | 377,191 |  |  | — |  |  | 401,444 |  |  |
Net income attributable to common stockholders | $ | 13,392 |  |  | $ | 371,645 |  |  | $ | 26,784 |  |  | $ | 390,583 |  |  |
Other comprehensive income - unrealized gain on interest rate swaps, net | 16,345 |  |  | 2,241 |  |  | 34,457 |  |  | 9,808 |  |  |
Comprehensive income attributable to common stockholders | $ | 29,737 |  |  | $ | 373,886 |  |  | $ | 61,241 |  |  | $ | 400,391 |  |  |
Weighted average number of common shares outstanding: |  |  |  |  |  |  |  |  |
Basic | 225,638,485 |  |  | 223,661,774 |  |  | 225,052,921 |  |  | 223,079,613 |  |  |
Diluted | 226,957,015 |  |  | 223,661,774 |  |  | 226,399,118 |  |  | 223,079,613 |  |  |
Net income per common share attributable to common stockholders: |  |  |  |  |  |  |  |  |
Basic: |  |  |  |  |  |  |  |  |
Continuing operations | $ | 0.06 |  |  | $ | (0.03) |  |  | $ | 0.12 |  |  | $ | (0.05) |  |  |
Discontinued operations | — |  |  | 1.69 |  |  | — |  |  | 1.80 |  |  |
Net income attributable to common stockholders | $ | 0.06 |  |  | $ | 1.66 |  |  | $ | 0.12 |  |  | $ | 1.75 |  |  |
Diluted: |  |  |  |  |  |  |  |  |
Continuing operations | $ | 0.06 |  |  | $ | (0.03) |  |  | $ | 0.12 |  |  | $ | (0.05) |  |  |
Discontinued operations | — |  |  | 1.69 |  |  | — |  |  | 1.80 |  |  |
Net income attributable to common stockholders | $ | 0.06 |  |  | $ | 1.66 |  |  | $ | 0.12 |  |  | $ | 1.75 |  |  |
Distributions declared per common share | $ | 0.10 |  |  | $ | 1.86 |  |  | $ | 0.30 |  |  | $ | 2.11 |  |  |

The accompanying notes are an integral part of these condensed consolidated financial statements.
4

Table of Contents
SILA REALTY TRUST, INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(in thousands, except share data)
(Unaudited)

| Common Stock |  |  |  |  |  |  |  |
| No. of Shares |  | Par Value |  | Additional Paid-in Capital |  | Distributions in Excess of Accumulated Earnings |  | Accumulated Other Comprehensive Income |  | Total Stockholders’ Equity
Balance, June 30, 2022 | 225,240,223 |  |  | $ | 2,252 |  |  | $ | 2,014,252 |  |  | $ | (432,101) |  |  | $ | 13,265 |  |  | $ | 1,597,668 |
Issuance of common stock under the distribution reinvestment plan | 767,755 |  |  | 8 |  |  | 6,296 |  |  | — |  |  | — |  |  | 6,304 |
Vesting of restricted stock | 50,689 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Stock-based compensation | — |  |  | — |  |  | 860 |  |  | — |  |  | — |  |  | 860 |
Repurchase of common stock | (225,136) |  |  | (2) |  |  | (1,844) |  |  | — |  |  | — |  |  | (1,846) |
Distributions to common stockholders | — |  |  | — |  |  | — |  |  | (22,882) |  |  | — |  |  | (22,882) |
Other comprehensive income | — |  |  | — |  |  | — |  |  | — |  |  | 16,345 |  |  | 16,345 |
Net income | — |  |  | — |  |  | — |  |  | 13,392 |  |  | — |  |  | 13,392 |
Balance, September 30, 2022 | 225,833,531 |  |  | $ | 2,258 |  |  | $ | 2,019,564 |  |  | $ | (441,591) |  |  | $ | 29,610 |  |  | $ | 1,609,841 |

| Common Stock |  |  |  |  |  |  |  |
| No. of Shares |  | Par Value |  | Additional Paid-in Capital |  | Distributions in Excess of Accumulated Earnings |  | Accumulated Other Comprehensive (Loss) Income |  | Total Stockholders’ Equity
Balance, December 31, 2021 | 224,179,939 |  |  | $ | 2,242 |  |  | $ | 2,004,404 |  |  | $ | (400,669) |  |  | $ | (4,847) |  |  | $ | 1,601,130 |
Issuance of common stock under the distribution reinvestment plan | 2,265,628 |  |  | 23 |  |  | 18,571 |  |  | — |  |  | — |  |  | 18,594 |
Vesting of restricted stock | 174,825 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Stock-based compensation | — |  |  | 1 |  |  | 3,033 |  |  | — |  |  | — |  |  | 3,034 |
Repurchase of common stock | (786,861) |  |  | (8) |  |  | (6,444) |  |  | — |  |  | — |  |  | (6,452) |
Distributions to common stockholders | — |  |  | — |  |  | — |  |  | (67,706) |  |  | — |  |  | (67,706) |
Other comprehensive income | — |  |  | — |  |  | — |  |  | — |  |  | 34,457 |  |  | 34,457 |
Net income | — |  |  | — |  |  | — |  |  | 26,784 |  |  | — |  |  | 26,784 |
Balance, September 30, 2022 | 225,833,531 |  |  | $ | 2,258 |  |  | $ | 2,019,564 |  |  | $ | (441,591) |  |  | $ | 29,610 |  |  | $ | 1,609,841 |

The accompanying notes are an integral part of these condensed consolidated financial statements.
5

Table of Contents
SILA REALTY TRUST, INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(in thousands, except share data)
(Unaudited)

| Common Stock |  |  |  |  |  |  |  |
| No. of Shares |  | Par Value |  | Additional Paid-in Capital |  | Distributions in Excess of Accumulated Earnings |  | Accumulated Other Comprehensive Loss |  | Total Stockholders’ Equity
Balance, June 30, 2021 | 223,285,587 |  |  | 2,233 |  |  | 1,995,298 |  |  | (345,941) |  |  | (12,877) |  |  | 1,638,713 |
Issuance of common stock under the distribution reinvestment plan | 826,280 |  |  | 8 |  |  | 6,909 |  |  | — |  |  | — |  |  | 6,917 |
Vesting of restricted stock | 18,075 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Stock-based compensation | — |  |  | — |  |  | 637 |  |  | — |  |  | — |  |  | 637 |
Distribution and servicing fees | — |  |  | — |  |  | 573 |  |  | — |  |  | — |  |  | 573 |
Repurchase of common stock | (303,247) |  |  | (3) |  |  | (2,483) |  |  | — |  |  | — |  |  | (2,486) |
Distributions to common stockholders | — |  |  | — |  |  | — |  |  | (416,636) |  |  | — |  |  | (416,636) |
Other comprehensive income | — |  |  | — |  |  | — |  |  | — |  |  | 2,241 |  |  | 2,241 |
Net income | — |  |  | — |  |  | — |  |  | 371,645 |  |  | — |  |  | 371,645 |
Balance, September 30, 2021 | 223,826,695 |  |  | $ | 2,238 |  |  | $ | 2,000,934 |  |  | $ | (390,932) |  |  | $ | (10,636) |  |  | $ | 1,601,604 |

| Common Stock |  |  |  |  |  |  |  |
| No. of Shares |  | Par Value |  | Additional Paid-in Capital |  | Distributions in Excess of Accumulated Earnings |  | Accumulated Other Comprehensive Loss |  | Total Stockholders’ Equity
Balance, December 31, 2020 | 222,045,522 |  |  | $ | 2,220 |  |  | $ | 1,983,361 |  |  | $ | (311,264) |  |  | $ | (20,444) |  |  | $ | 1,653,873 |
Issuance of common stock under the distribution reinvestment plan | 2,532,368 |  |  | 25 |  |  | 21,725 |  |  | — |  |  | — |  |  | 21,750 |
Vesting of restricted stock | 21,386 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Stock-based compensation | — |  |  | — |  |  | 1,756 |  |  | — |  |  | — |  |  | 1,756 |
Distribution and servicing fees | — |  |  | — |  |  | 649 |  |  | — |  |  | — |  |  | 649 |
Repurchase of common stock | (772,581) |  |  | (7) |  |  | (6,557) |  |  | — |  |  | — |  |  | (6,564) |
Distributions to common stockholders | — |  |  | — |  |  | — |  |  | (470,251) |  |  | — |  |  | (470,251) |
Other comprehensive income | — |  |  | — |  |  | — |  |  | — |  |  | 9,808 |  |  | 9,808 |
Net income | — |  |  | — |  |  | — |  |  | 390,583 |  |  | — |  |  | 390,583 |
Balance, September 30, 2021 | 223,826,695 |  |  | $ | 2,238 |  |  | $ | 2,000,934 |  |  | $ | (390,932) |  |  | $ | (10,636) |  |  | $ | 1,601,604 |

The accompanying notes are an integral part of these condensed consolidated financial statements.
6

Table of Contents
SILA REALTY TRUST, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(Unaudited)

| Nine Months Ended September 30,
| 2022 |  | 2021 |  |
Cash flows from operating activities: |  |  |  |  |
Net income attributable to common stockholders | $ | 26,784 |  |  | $ | 390,583 |  |  |
Adjustments to reconcile net income attributable to common stockholders to net cash provided by operating activities: |  |  |  |  |
Depreciation and amortization | 54,443 |  |  | 64,857 |  |  |
Amortization of deferred financing costs | 1,267 |  |  | 2,761 |  |  |
Amortization of above- and below-market leases | 362 |  |  | (1,239) |  |  |
Other amortization expenses | 1,989 |  |  | 2,159 |  |  |
Gain on real estate disposition from continuing operations | (460) |  |  | — |  |  |
Gain on real estate dispositions of discontinued operations | — |  |  | (395,801) |  |  |
Loss on extinguishment of debt | 3,367 |  |  | 28,751 |  |  |
Impairment losses | 7,387 |  |  | 27,837 |  |  |
Straight-line rent adjustments | (7,530) |  |  | (12,492) |  |  |
Stock-based compensation | 3,034 |  |  | 1,756 |  |  |
Changes in operating assets and liabilities: |  |  |  |  |
Accounts payable and other liabilities | (2,770) |  |  | (7,172) |  |  |
Other assets | 1,158 |  |  | 2,816 |  |  |
Net cash provided by operating activities | 89,031 |  |  | 104,816 |  |  |
Cash flows from investing activities: |  |  |  |  |
Investment in real estate | (157,194) |  |  | (25,048) |  |  |
Consideration paid for the internalization transaction | — |  |  | (15,000) |  |  |
Proceeds from real estate disposition | 22,822 |  |  | 1,295,367 |  |  |
Capital expenditures | (7,577) |  |  | (20,323) |  |  |
Change in deposits and other costs for investments in real estate | — |  |  | (400) |  |  |
Collection of notes receivable | — |  |  | 28,500 |  |  |
Net cash (used in) provided by investing activities | (141,949) |  |  | 1,263,096 |  |  |
Cash flows from financing activities: |  |  |  |  |
Payments on notes payable | — |  |  | (453,422) |  |  |
Proceeds from credit facility | 845,000 |  |  | 15,000 |  |  |
Payments on credit facility | (745,000) |  |  | (433,000) |  |  |
Payments for extinguishment of debt | (4) |  |  | (29,244) |  |  |
Payments of deferred financing costs | (6,936) |  |  | (436) |  |  |
Repurchase of common stock | (6,452) |  |  | (6,564) |  |  |
Offering costs on issuance of common stock | (193) |  |  | (1,807) |  |  |
Distributions to common stockholders | (48,920) |  |  | (450,143) |  |  |
Net cash provided by (used in) financing activities | 37,495 |  |  | (1,359,616) |  |  |
Net change in cash, cash equivalents and restricted cash | (15,423) |  |  | 8,296 |  |  |
Cash, cash equivalents and restricted cash - Beginning of period | 32,880 |  |  | 67,909 |  |  |
Cash, cash equivalents and restricted cash - End of period | $ | 17,457 |  |  | $ | 76,205 |  |  |
Supplemental cash flow disclosure: |  |  |  |  |
Interest paid, net of interest capitalized of $48 and $296, respectively | $ | 12,451 |  |  | $ | 34,142 |  |  |
Supplemental disclosure of non-cash transactions: |  |  |  |  |
Common stock issued through distribution reinvestment plan | $ | 18,594 |  |  | $ | 21,750 |  |  |
Change in accrued distributions to common stockholders | $ | 192 |  |  | $ | (1,642) |  |  |
Change in accounts payable and other liabilities related to capital expenditures | $ | (3,295) |  |  | $ | 605 |  |  |
Right-of-use assets obtained in exchange for new operating lease liabilities | $ | 15,305 |  |  | $ | 625 |  |  |

The accompanying notes are an integral part of these condensed consolidated financial statements.
7

Table of Contents
SILA REALTY TRUST, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
September 30, 2022
Note 1—Organization and Business Operations
Sila Realty Trust, Inc., or the Company, is a Maryland corporation, headquartered in Tampa, Florida, that has elected, and currently qualifies, to be taxed as a real estate investment trust, or a REIT, for federal income tax purposes. The Company invests in high-quality healthcare properties leased to long-term tenants. The Company is primarily focused on investing in and managing strategic healthcare assets across the continuum of care, with emphasis on lower cost patient settings, which, the Company believes, typically generate predictable, durable and growing income streams. The Company may also make other real estate-related investments in healthcare properties, which may include equity or debt interests in other real estate entities.
Substantially all of the Company’s business is conducted through Sila Realty Operating Partnership, LP, a Delaware limited partnership, or the Operating Partnership. The Company is the sole general partner of the Operating Partnership and directly, and through its wholly-owned subsidiaries, owns 100% of the Operating Partnership.
The Company formerly invested in data center properties and during the second quarter of 2021, the Company's board of directors, or the Board, made a determination to sell the Company's data center properties. On May 19, 2021, the Company and certain of its wholly-owned subsidiaries entered into a purchase and sale agreement, or the PSA, for the sale of up to 29 data center properties owned by the Company, which constituted the entirety of the Company's data center segment. The decision of the Board to sell the data center properties, as well as the execution of the PSA, represented a strategic shift that had a major effect on the Company's results and operations for the periods presented. As of December 31, 2021, the Company had no assets or liabilities related to the data center segment. The operations of the data center segment have been classified as income from discontinued operations on the condensed consolidated statements of comprehensive income for the three and nine months ended September 30, 2021.
On July 22, 2021, the Company completed the sale of its data center segment, or the Data Center Sale, for an aggregate sale price of $1,320,000,000, and generated net proceeds of approximately $1,295,367,000. Concurrently, the Board declared a special cash distribution of $1.75 per share of Class A, Class I, Class T and Class T2 shares of common stock. The special cash distribution was funded with the proceeds from the Data Center Sale. The special cash distribution was paid on July 30, 2021 to stockholders of record at the close of business on July 26, 2021, in an aggregate amount of approximately $392,685,000.
Except as the context otherwise requires, the “Company” refers to Sila Realty Trust, Inc., the Operating Partnership and their wholly-owned subsidiaries.
Note 2—Summary of Significant Accounting Policies
The accompanying condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the Company’s audited consolidated financial statements as of and for the year ended December 31, 2021, and related notes thereto set forth in the Company’s Annual Report on Form 10-K, filed with the SEC on March 29, 2022. In the opinion of management, all adjustments, consisting of a normal and recurring nature considered for a fair presentation, have been included. Operating results for the three and nine months ended September 30, 2022, are not necessarily indicative of the results that may be expected for the year ending December 31, 2022.
Principles of Consolidation and Basis of Presentation
The accompanying condensed consolidated financial statements include the accounts of the Company, the Operating Partnership, and their wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates
The preparation of the condensed consolidated financial statements and accompanying notes in conformity with GAAP requires the Company to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. These estimates are made and evaluated on an ongoing basis using information that is currently available as well as various other assumptions believed to be reasonable under the circumstances. Actual results could differ from those estimates.
8

Table of Contents
Restricted Cash
Restricted cash consists of cash held in escrow accounts for tenant and capital improvements in accordance with the respective tenants' lease agreement. Restricted cash is reported in other assets, net, in the accompanying condensed consolidated balance sheets.
The following table presents a reconciliation of the beginning of period and end of period cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets to the totals shown in the condensed consolidated statements of cash flows (amounts in thousands):

|  | Nine Months Ended September 30, |  |
|  | 2022 |  | 2021 |  |
Beginning of period: |  |  |  |  |  |
Cash and cash equivalents |  | $ | 32,359 |  |  | $ | 53,174 |  |  |
Restricted cash |  | 521 |  |  | 14,735 |  |  |
Cash, cash equivalents and restricted cash |  | $ | 32,880 |  |  | $ | 67,909 |  |  |
End of period: |  |  |  |  |  |
Cash and cash equivalents |  | $ | 17,291 |  |  | $ | 75,363 |  |  |
Restricted cash |  | 166 |  |  | 842 |  |  |
Cash, cash equivalents and restricted cash |  | $ | 17,457 |  |  | $ | 76,205 |  |  |

Reclassifications
Certain amounts in the condensed consolidated financial statements for prior periods have been reclassified to conform to the current period presentation.
Note 3—Real Estate Investments
2022 Real Estate Property Acquisitions
During the nine months ended September 30, 2022, the Company purchased seven real estate properties in five separate transactions, or the 2022 Acquisitions, which were each determined to be asset acquisitions. The Company allocated the purchase price of the 2022 Acquisitions to tangible assets, consisting of land, building and improvements, tenant improvements, and acquired intangible assets and liabilities, consisting of in-place and above and below market leases, based on the relative fair value method of allocating all accumulated costs.
The following table summarizes the consideration transferred for the 2022 Acquisitions during the nine months ended September 30, 2022:

Property Description |  | Date Acquired |  | Ownership Percentage |  | Purchase Price (amount in thousands)
Yukon Healthcare Facility |  | 03/10/2022 |  | 100% |  | $ | 19,554 |
Pleasant Hills Healthcare Facility |  | 05/12/2022 |  | 100% |  | 14,303 |
Prosser Healthcare Facilities (1) |  | 05/20/2022 |  | 100% |  | 8,593 |
Tampa Healthcare Facility II |  | 07/20/2022 |  | 100% |  | 51,259 |
Escondido Healthcare Facility |  | 07/21/2022 |  | 100% |  | 63,485 |
Total |  |  |  |  |  | $ | 157,194 |

(1) The Prosser Healthcare Facilities consist of three healthcare properties.
9

Table of Contents
The following table summarizes the Company's purchase price allocation of the 2022 Acquisitions during the nine months ended September 30, 2022 (amounts in thousands):

|  | Total
Land |  | $ | 2,646 |
Building and improvements |  | 136,938 |
Tenant improvements |  | 4,840 |
In-place leases |  | 12,779 |
Above-market leases |  | 454 |
Total assets acquired |  | 157,657 |
Below-market leases |  | (463) |
Net assets acquired |  | $ | 157,194 |

Acquisition costs associated with transactions determined to be asset acquisitions are capitalized. The Company capitalized acquisition costs of approximately $617,000 related to the 2022 Acquisitions, which are included in the Company's allocation of the real estate acquisitions presented above.
2022 Real Estate Property Disposition
On February 10, 2022, the Company sold one land parcel that formerly contained a healthcare property, or the 2022 Disposition, for an aggregate sale price of $24,000,000 and generated net proceeds of $22,701,000. For the nine months ended September 30, 2022, the Company recognized an aggregate gain on sale of $460,000, which is presented in gain on real estate disposition in the condensed consolidated statements of comprehensive income.
Concentration of Credit Risk and Significant Leases
As of September 30, 2022, the Company had one exposure to geographic concentration that accounted for greater than 10.0% of rental revenue for the nine months ended September 30, 2022. Real estate investments located in the Houston-The Woodlands-Sugar Land, Texas metropolitan statistical area accounted for 10.9% of rental revenue for the nine months ended September 30, 2022.
As of September 30, 2022, the Company had one exposure to tenant concentration that accounted for greater than 10.0% of rental revenue for the nine months ended September 30, 2022. The leases with tenants at healthcare properties under common control of Post Acute Medical, LLC and its affiliates accounted for 14.2% of rental revenue for the nine months ended September 30, 2022.
Impairments of Real Estate, Goodwill, Acquired Intangible Assets and Acquired Intangible Liabilities
During the nine months ended September 30, 2022, the Company recorded an impairment loss on real estate, including goodwill, in the aggregate amount of $7,387,000 related to a healthcare property. The fair value of this property was determined based on a market approach model using a signed purchase and sale agreement to estimate the fair value and classified within Level 2 of the fair value hierarchy. In addition, during the nine months ended September 30, 2022, the Company recognized an impairment of one in-place lease intangible asset in the amount of approximately $380,000 related to a tenant in this property. During the three months ended September 30, 2022, the Company did not have impairment of real estate, goodwill, acquired intangible assets or acquired intangible liabilities.
During the three months ended September 30, 2021, the Company recorded an impairment loss on real estate in the amount of $10,241,000 related to one healthcare property for which the carrying value exceeded the estimated fair value.
During the three months ended September 30, 2021, the Company did not have impairment of goodwill, acquired intangible assets or acquired intangible liabilities.
During the nine months ended September 30, 2021, the Company recorded impairment losses on real estate, including goodwill, in the aggregate amount of $27,837,000 related to one healthcare property held for use, one healthcare property classified as held for sale and one land parcel that formerly contained a healthcare property classified as held for sale, for which the carrying values exceeded the estimated fair values less costs to sell. The fair value of the properties with impairment charges during the three and nine months September 30, 2021, were determined based on a market approach model using comparable properties adjusted for differences in characteristics to estimate the fair value and classified within Level 2 of the fair value hierarchy. During the nine months ended September 30, 2021, the Company recognized an impairment of one in-place lease intangible asset in the amount of approximately $1,120,000 related to one healthcare tenant. The impaired properties for the three and nine months ended September 30, 2021 have all been subsequently sold.
10

Table of Contents
During the nine months ended September 30, 2021, the Company did not have impairment of acquired intangible liabilities.
Impairment charges on real estate and goodwill are recorded as impairment losses in the accompanying condensed consolidated statements of comprehensive income. Impairment of the in-place leases is included in depreciation and amortization in the accompanying condensed consolidated statements of comprehensive income.
Note 4—Held for Sale and Discontinued Operations
On August 30, 2021, the Company entered into a purchase and sale agreement for the sale of one land parcel that formerly contained a healthcare property. The purchase and sale agreement required that the structures on the healthcare property be demolished prior to the sale. The structures on the property were demolished and the property consisted solely of land as of December 31, 2021. The Company classified the land as held for sale as of December 31, 2021. The Company sold the land held for sale on February 10, 2022.
The following table presents the major classes of the assets and liabilities held for sale as presented separately in the condensed consolidated balance sheet as of December 31, 2021 (amounts in thousands):

|  |  | December 31, 2021
Assets: |  |  |
Real estate: |  |  |
Land |  |  | $ | 22,241 |
Buildings and improvements, net |  |  | — |
Total real estate, net |  |  | 22,241 |
Other assets, net |  |  | 329 |
Assets held for sale |  |  | $ | 22,570 |
Liabilities: |  |  |
Accounts payable and other liabilities |  |  | 698 |
Liabilities held for sale |  |  | $ | 698 |

The operations reflected in income from discontinued operations (which consisted solely of the Company's former data center segment) on the condensed consolidated statements of comprehensive income for the three and nine months ended September 30, 2021, were as follows (amounts in thousands):

|  |  | Three Months Ended September 30, |  |  |  | Nine Months Ended September 30,
|  |  | 2021 |  |  |  | 2021 |  |
Revenue: |  |  |  |  |  |  |  |  |
Rental revenue |  |  | $ | 6,180 |  |  |  |  | $ | 57,903 |  |  |
Lease termination revenue |  |  | 75 |  |  |  |  | 7,075 |  |  |
Total revenue |  |  | 6,255 |  |  |  |  | 64,978 |  |  |
Expenses: |  |  |  |  |  |  |  |  |
Rental expenses |  |  | 2,504 |  |  |  |  | 15,737 |  |  |
Depreciation and amortization |  |  | 35 |  |  |  |  | 11,759 |  |  |
Total expenses |  |  | 2,539 |  |  |  |  | 27,496 |  |  |
Interest and other expense, net (1) |  |  | 25,085 |  |  |  |  | 31,839 |  |  |
Income from discontinued operations |  |  | (21,369) |  |  |  |  | 5,643 |  |  |
Gain on real estate dispositions(2) |  |  | 398,560 |  |  |  |  | 395,801 |  |  |
Net income from discontinued operations attributable to common stockholders |  |  | $ | 377,191 |  |  |  |  | $ | 401,444 |  |  |

(1) Interest expense attributable to discontinued operations for the three and nine months ended September 30, 2021 was $25,085,000 and $31,856,000, respectively, which related to notes payable on certain data center properties. On July 22, 2021, in connection with the Data Center Sale, the Company paid off all data center and healthcare related notes payable, with an outstanding principal balance of $450,806,000 at the time of repayment.
11

Table of Contents
(2) Represents gain on real estate dispositions related to the Data Center Sale that occurred on July 22, 2021. The Company recognized $2,759,000 in transaction costs during the second quarter of 2021, resulting in the total gain being higher during the three months ended September 30, 2021.
Capital expenditures on a cash basis for the nine months ended September 30, 2021, were $2,215,000, related to properties classified within discontinued operations.
There were no significant non-cash operating or investing activities for the properties classified within discontinued operations for the nine months ended September 30, 2021.
Note 5—Acquired Intangible Assets, Net
Acquired intangible assets, net, consisted of the following as of September 30, 2022 and December 31, 2021 (amounts in thousands, except weighted average remaining life amounts):

| September 30, 2022 |  | December 31, 2021
In-place leases, net of accumulated amortization of $79,932 and $66,579, respectively (with a weighted average remaining life of 9.1 years and 9.5 years, respectively) | $ | 164,702 |  |  | $ | 168,012 |
Above-market leases, net of accumulated amortization of $5,956 and $4,488, respectively (with a weighted average remaining life of 8.1 years and 8.8 years, respectively) | 12,613 |  |  | 13,627 |
| $ | 177,315 |  |  | $ | 181,639 |

The aggregate weighted average remaining life of the acquired intangible assets was 9.1 years and 9.5 years as of September 30, 2022 and December 31, 2021, respectively.
Amortization of acquired intangible assets was $5,839,000 and $5,507,000 for the three months ended September 30, 2022 and 2021, respectively, and $17,557,000 and $17,624,000 for the nine months ended September 30, 2022 and 2021, respectively. Amortization of in-place leases is included in depreciation and amortization, and amortization of above-market leases is recorded as an adjustment to rental revenue in the accompanying condensed consolidated statements of comprehensive income.
Note 6—Acquired Intangible Liabilities, Net
Acquired intangible liabilities, net, consisted of the following as of September 30, 2022 and December 31, 2021 (amounts in thousands, except weighted average remaining life amounts):

| September 30, 2022 |  | December 31, 2021
Below-market leases, net of accumulated amortization of $5,550 and $4,444, respectively (with a weighted average remaining life of 8.6 years and 9.3 years, respectively) | $ | 12,319 |  |  | $ | 12,962 |

Amortization of below-market leases was $373,000 and $338,000 for the three months ended September 30, 2022 and 2021, respectively, and $1,106,000 and $979,000 for the nine months ended September 30, 2022 and 2021, respectively. Amortization of below-market leases is recorded as an adjustment to rental revenue in the accompanying condensed consolidated statements of comprehensive income.
12

Table of Contents
Note 7—Leases
Lessor
Rental Revenue
The Company’s real estate properties are leased to tenants under operating leases with varying terms. Typically, the leases have provisions to extend the terms of the lease agreements. The Company retains substantially all of the risks and benefits of ownership of the real estate properties leased to tenants.
Future rent to be received from the Company's investments in real estate assets under the terms of non-cancellable operating leases in effect as of September 30, 2022, for the three months ending December 31, 2022, and for each of the next four years ending December 31 and thereafter, are as follows (amounts in thousands):

Year |  | Amount
Three months ending December 31, 2022 |  | $ | 42,292 |
2023 |  | 172,586 |
2024 |  | 173,961 |
2025 |  | 170,002 |
2026 |  | 163,163 |
Thereafter |  | 1,096,932 |
Total |  | $ | 1,818,936 |

Lessee
The Company is subject to various non-cancellable operating ground lease agreements and a finance ground lease agreement on which certain of its properties reside. In addition, the Company has non-cancellable corporate-related operating leases.
The Company's operating leases and the finance lease do not provide an implicit interest rate. In order to calculate the present value of the remaining operating and finance lease payments, the Company used incremental borrowing rates, or IBRs, adjusted for a number of factors. The determination of an appropriate IBR involves multiple inputs and judgments. The Company determined its IBRs considering the general economic environment, term of the underlying leases, and various financing and asset specific adjustments to ensure the IBRs are appropriate for the intended use of the underlying operating or finance leases.
The Company's right-of-use assets classified as operating leases and finance lease are recorded in right-of-use assets on the condensed consolidated balance sheets.
As of September 30, 2022, the Company's IBRs for its operating leases were between 2.5% and 6.4%, with a weighted average IBR of 5.5%. The weighted average remaining lease term for the Company's operating leases was 37.4 years and 36.1 years as of September 30, 2022 and December 31, 2021, respectively.
As of September 30, 2022, the Company's IBR for its finance lease was 5.3%. The remaining lease term for the Company's finance lease was 41.7 years and 42.4 years as of September 30, 2022 and December 31, 2021, respectively.
The future rent payments, discounted by the Company's IBRs, under non-cancellable leases in effect as of September 30, 2022, for the three months ending December 31, 2022, and for each of the next four years ending December 31 and thereafter, are as follows (amounts in thousands):

Year |  | Operating |  | Finance
Three months ending December 31, 2022 |  | $ | 622 |  |  | $ | 34 |
2023 |  | 2,539 |  |  | 136 |
2024 |  | 2,606 |  |  | 141 |
2025 |  | 2,625 |  |  | 143 |
2026 |  | 2,572 |  |  | 143 |
Thereafter |  | 103,696 |  |  | 6,441 |
Total undiscounted rental payments |  | 114,660 |  |  | 7,038 |
Less imputed interest |  | (75,671) |  |  | (4,387) |
Total lease liabilities |  | $ | 38,989 |  |  | $ | 2,651 |

13

Table of Contents
The following table provides details of the Company's total lease costs for the three and nine months ended September 30, 2022 and 2021 (amounts in thousands):

|  |  |  | Three Months Ended September 30, |  |  | Nine Months Ended September 30,
|  | Location in Condensed Consolidated Statements of Comprehensive Income |  | 2022 |  | 2021 |  |  | 2022 |  | 2021 |  |
Operating lease costs: |  |  |  |  |  |  |  |  |  |  |  |  |
Ground lease costs |  | Rental expenses |  | $ | 575 |  |  | $ | 422 |  |  |  | $ | 1,442 |  |  | $ | 1,266 |  |  |
Ground lease costs (1) |  | Income from discontinued operations |  | — |  |  | 25 |  |  |  | — |  |  | 414 |  |  |
Corporate operating lease costs |  | General and administrative expenses |  | 182 |  |  | 297 |  |  |  | 559 |  |  | 825 |  |  |
Finance lease costs: |  |  |  |  |  |  |  |  |  |  |  |  |
Amortization of right-of-use asset |  | Depreciation and amortization |  | $ | 5 |  |  | $ | 5 |  |  |  | $ | 15 |  |  | $ | 14 |  |  |
Interest on lease liability |  | Interest and other expense, net |  | 35 |  |  | 35 |  |  |  | 105 |  |  | 102 |  |  |

(1)Amount relates to lease costs attributable to operating ground leases related to data center properties disposed of in the Data Center Sale on July 22, 2021.
Note 8—Other Assets, Net
Other assets, net, consisted of the following as of September 30, 2022 and December 31, 2021 (amounts in thousands):

| September 30, 2022 |  | December 31, 2021
Deferred financing costs, related to the revolver portion of the credit facility, net of accumulated amortization of $635 and $8,332, respectively | $ | 3,432 |  |  | $ | 482 |
Leasing commissions, net of accumulated amortization of $151 and $121, respectively | 792 |  |  | 780 |
Restricted cash | 166 |  |  | 521 |
Tenant receivables | 1,637 |  |  | 1,851 |
Straight-line rent receivable | 63,255 |  |  | 55,725 |
Prepaid and other assets | 3,739 |  |  | 4,835 |
Derivative assets | 29,724 |  |  | 2,171 |
| $ | 102,745 |  |  | $ | 66,365 |

Note 9—Accounts Payable and Other Liabilities
Accounts payable and other liabilities consisted of the following as of September 30, 2022 and December 31, 2021 (amounts in thousands):

| September 30, 2022 |  | December 31, 2021
Accounts payable and accrued expenses | $ | 5,482 |  |  | $ | 9,409 |
Accrued interest expense | 1,563 |  |  | 1,626 |
Accrued property taxes | 2,794 |  |  | 2,913 |
Accrued personnel costs | 3,138 |  |  | 4,198 |
Distribution and servicing fees | — |  |  | 182 |
Distributions payable to stockholders | 7,456 |  |  | 7,355 |
Performance DSUs distributions payable | 485 |  |  | 394 |
Tenant deposits | 877 |  |  | 802 |
Deferred rental income | 6,784 |  |  | 7,100 |
Derivative liabilities | — |  |  | 5,618 |
| $ | 28,579 |  |  | $ | 39,597 |

14

Table of Contents
Note 10—Credit Facility
The Company's outstanding credit facility as of September 30, 2022 and December 31, 2021 consisted of the following (amounts in thousands):

| September 30, 2022 |  | December 31, 2021
Variable rate revolving line of credit | 25,000 |  |  | — |
Variable rate term loans fixed through interest rate swaps | 485,000 |  |  | 400,000 |
Variable rate term loans | 90,000 |  |  | 100,000 |
Total credit facility, principal amount outstanding | 600,000 |  |  | 500,000 |
Unamortized deferred financing costs related to the term loan credit facility | (2,570) |  |  | (3,226) |
Total credit facility, net of deferred financing costs | $ | 597,430 |  |  | $ | 496,774 |

Significant activities regarding the credit facility during the nine months ended September 30, 2022, include:
•On February 15, 2022, the Company, the Operating Partnership and certain of the Company's subsidiaries, entered into a senior unsecured revolving credit agreement, or the Revolving Credit Agreement, with Truist Bank, as Administrative Agent for the lenders, for aggregate commitments available of up to $500,000,000, which may be increased, subject to lender approval, through incremental term loans and/or revolving loan commitments in an aggregate amount not to exceed $1,000,000,000. The maturity date for the Revolving Credit Agreement is February 15, 2026, which, at the Company's election, may be extended for a period of six-months on no more than two occasions, subject to certain conditions, including the payment of an extension fee. The Revolving Credit Agreement was entered into to replace the Company's prior $500,000,000 revolving line of credit, which had a maturity date of April 27, 2022, with the option to extend for one twelve-month period. The Company did not exercise the option to extend. Upon closing of the Revolving Credit Agreement, the Company extinguished all commitments associated with the prior revolving line of credit. Simultaneously with the Revolving Credit Agreement’s execution, on February 15, 2022, the Company, the Operating Partnership, and certain of the Company's subsidiaries, entered into the senior unsecured term loan agreement, or the 2024 Term Loan Agreement, with Truist Bank, as Administrative Agent for the lenders. The 2024 Term Loan Agreement was fully funded at closing, and is made up of aggregate commitments of $300,000,000, which may be increased, subject to lender approval, to an aggregate amount not to exceed $600,000,000. The 2024 Term Loan Agreement has a maturity date of December 31, 2024, and, at the Company's election, may be extended for a period of six-months on no more than two occasions, subject to the satisfaction of certain conditions, including the payment of an extension fee. The 2024 Term Loan Agreement was entered into to replace the Company's prior term loan, which was paid off in its entirety upon closing of the Revolving Credit Agreement and the 2024 Term Loan Agreement.
•In connection with the repayment of our prior credit facility, the Company recognized a loss on extinguishment of debt of $3,367,000 during the nine months ended September 30, 2022, which included loan costs in the amount of $4,000 and accelerated unamortized debt issuance costs of $3,363,000. The loss on extinguishment of debt was recognized in interest and other expense, net, in the accompanying condensed consolidated statements of comprehensive income.
•On April 8, 2022, the Company entered into five interest rate swap agreements, two of which have an effective date of May 2, 2022 and an aggregate notional amount of $85,000,000, and three of which have an effective date of May 1, 2023 and an aggregate notional amount of $150,000,000.
•On May 17, 2022, the Company, the Operating Partnership and certain of the Company’s subsidiaries, entered into a new senior unsecured term loan agreement, or the 2028 Term Loan Agreement, with Truist Bank, as Administrative Agent for the lenders, for aggregate commitments of up to $275,000,000, of which $205,000,000 was drawn at closing to pay down the Company’s Revolving Credit Agreement in its entirety. The remainder of the commitments were available for three months following the closing date, or the Availability Period, and were available in no more than three subsequent draws with a minimum of $20,000,000 per draw, or the remaining commitments available. After the Availability Period, the undrawn portion was no longer available. If the committed amount was not fully drawn within 60 days of closing, the Company was required to pay a fee to the lenders, calculated as 0.25% per annum on the average daily amount of the undrawn portion, payable quarterly in arrears, until the earlier of (i) the date when the commitments have been funded in full, or (ii) August 17, 2022. The 2028 Term Loan Agreement may be increased, subject to lender approval, to an aggregate amount not to exceed $500,000,000 and has a maturity date of January 31, 2028. The 2028 Term Loan Agreement is pari passu with the Company’s Revolving Credit Agreement and 2024 Term Loan Agreement. The Company refers to the 2028 Term Loan Agreement, the Revolving Credit Agreement and the 2024 Term Loan Agreement, collectively, as the “Unsecured Credit Facility,” which has aggregate commitments available of $1,075,000,000. At the Company’s election, loans under the Unsecured Credit Facility may be made as Base Rate Loans or Secured Overnight Financing Rate, or SOFR, Loans. The applicable margin for loans that are Base Rate Loans is
15

Table of Contents
adjustable based on a total leverage ratio, ranging from 0.25% to 0.90%. The applicable margin for loans that are SOFR Loans is adjustable based on a total leverage ratio, ranging from 1.25% to 1.90%. In addition to interest, the Company is required to pay a fee on the unused portion of the lenders’ commitments under the Revolving Credit Agreement at a rate per annum equal to 0.20% if the average daily amount outstanding under the Revolving Credit Agreement is less than 50% of the aggregate commitments, or 0.15% if the average daily amount outstanding under the Revolving Credit Agreement is equal to or greater than 50% of the aggregate commitments. The unused fee is payable quarterly in arrears.
•On July 12, 2022 and July 20, 2022, the Company drew $50,000,000 and $20,000,000, respectively, on the 2028 Term Loan Agreement, to fund acquisitions. As of July 20, 2022, the 2028 Term Loan Agreement commitments were fully funded.
•During the nine months ended September 30, 2022, the Company drew $70,000,000 on the Revolving Credit Agreement to fund acquisitions and repaid $40,000,000 on the Revolving Credit Agreement, with proceeds from dispositions and cash flows from operations.
The principal payments due on the Unsecured Credit Facility as of September 30, 2022, for the three months ending December 31, 2022, and for each of the next four years ending December 31 and thereafter, are as follows (amounts in thousands):

Year |  | Amount
Three months ending December 31, 2022 |  | $ | — |
2023 |  | — |
2024 |  | 300,000 |
2025 |  | — |
2026 |  | 25,000 |
Thereafter |  | 275,000 |
|  | $ | 600,000 |

Note 11—Fair Value
Credit facility—The outstanding principal of the credit facility was $600,000,000 and $500,000,000, which approximated its fair value due to the variable nature of the terms as of September 30, 2022 and December 31, 2021, respectively.
The fair value of the Company's credit facility is estimated based on the interest rates currently offered to the Company by its financial institutions.
Derivative instruments—Considerable judgment is necessary to develop estimated fair values of financial instruments. Accordingly, the estimates presented herein are not necessarily indicative of the amount the Company could realize, or be liable for, on disposition of the financial instruments. The Company determined that the majority of the inputs used to value its interest rate swaps fall within Level 2 of the fair value hierarchy. The credit valuation adjustments associated with these instruments utilize Level 3 inputs, such as estimates of current credit spreads, to evaluate the likelihood of default by the Company and the respective counterparty. However, as of September 30, 2022, the Company assessed the significance of the impact of the credit valuation adjustments on the overall valuation of its derivative positions and determined that the credit valuation adjustments are not significant to the overall valuation of its interest rate swaps. As a result, the Company determined that its interest rate swaps valuation in its entirety is classified in Level 2 of the fair value hierarchy. See Note 12—"Derivative Instruments and Hedging Activities" for further discussion of the Company's derivative instruments.
16

Table of Contents
The following tables show the fair value of the Company’s financial assets and liabilities that are required to be measured at fair value on a recurring basis as of September 30, 2022 and December 31, 2021 (amounts in thousands):

| September 30, 2022
| Fair Value Hierarchy |  |
| Quoted Prices in Active Markets for Identical Assets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3) |  | Total Fair Value
Assets: |  |  |  |  |  |  |
Derivative assets | $ | — |  |  | $ | 29,724 |  |  | $ | — |  |  | $ | 29,724 |
Total assets at fair value | $ | — |  |  | $ | 29,724 |  |  | $ | — |  |  | $ | 29,724 |

| December 31, 2021
| Fair Value Hierarchy |  |
| Quoted Prices in Active Markets for Identical Assets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3) |  | Total Fair Value
Assets: |  |  |  |  |  |  |
Derivative assets | $ | — |  |  | $ | 2,171 |  |  | $ | — |  |  | $ | 2,171 |
Total assets at fair value | $ | — |  |  | $ | 2,171 |  |  | $ | — |  |  | $ | 2,171 |
Liabilities: |  |  |  |  |  |  |
Derivative liabilities | $ | — |  |  | $ | 5,618 |  |  | $ | — |  |  | $ | 5,618 |
Total liabilities at fair value | $ | — |  |  | $ | 5,618 |  |  | $ | — |  |  | $ | 5,618 |

Derivative assets and liabilities are reported in the condensed consolidated balance sheets as other assets, net, and accounts payable and other liabilities, respectively.
Note 12—Derivative Instruments and Hedging Activities
Cash Flow Hedges of Interest Rate Risk
The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish these objectives, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable rate amounts from a counterparty in exchange for the Company making fixed rate payments over the life of the agreements without exchange of the underlying notional amount.
Accounting for changes in the fair value of a derivative instrument depends on the intended use and designation of the derivative instrument. The Company designated the interest rate swaps as cash flow hedges to hedge the variability of the anticipated cash flows on its variable rate credit facility. Changes in the fair value of derivatives designated, and that qualify, as cash flow hedges are recorded in accumulated other comprehensive income (loss) in the accompanying condensed consolidated statements of stockholders' equity and are subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings.
In connection with the Data Center Sale on July 22, 2021, the Company terminated eight interest rate swap agreements related to mortgage notes fixed through interest rate swaps. Prior to the termination of the eight interest rate swaps, the Company de-designated and then formally re-designated these hedged transactions. During the three and nine months ended September 30, 2022, as the hedged forecasted transactions affected earnings, the Company reclassified approximately $291,000 and $1,274,000, respectively, from accumulated other comprehensive income (loss) to interest and other expense, net, related to the swap terminations, in the accompanying condensed consolidated statements of comprehensive income.
Amounts reported in accumulated other comprehensive income (loss) related to derivatives will be reclassified to interest and other expense, net, as interest is incurred on the Company’s variable rate debt. During the next twelve months, the Company estimates that an additional $15,406,000 will be reclassified from accumulated other comprehensive income (loss) as an increase to earnings.
17

Table of Contents
The following table summarizes the notional amount and fair value of the Company’s derivative instruments (amounts in thousands):

Derivatives Designated as Hedging Instruments |  | Balance Sheet Location |  | Effective Dates (2), (3) |  | Maturity Dates (2) |  | September 30, 2022 |  | December 31, 2021
Outstanding Notional Amount (2) |  | Fair Value of |  | Outstanding Notional Amount |  | Fair Value of
Assets |  | (Liabilities) |  | Assets |  | (Liabilities)
Interest rate swaps |  | (1) |  | 05/01/2022 to 05/01/2023 |  | 04/27/2023 to 01/31/2028 |  | $ | 485,000 |  |  | $ | 29,724 |  |  | $ | — |  |  | $ | 400,000 |  |  | $ | 2,171 |  |  | $ | (5,618) |

(1) Derivative assets and liabilities are reported in the condensed consolidated balance sheets as other assets, net, and accounts payable and other liabilities, respectively.
(2) During the three months ended June 30, 2022, the Company entered into three interest rate swap agreements with an aggregate notional amount of $150,000,000, that have an effective date of May 1, 2023, to replace two interest rate swaps with an aggregate notional amount of $150,000,000 that have a maturity date of April 27, 2023.
(3) In May 2022, the Company entered into bilateral agreements with its swap counterparties to transition all of its interest rate swap agreements to SOFR. As of June 30, 2022, all of the Company's interest rate swap agreements were indexed to SOFR.
The notional amount under the agreements is an indication of the extent of the Company’s involvement in each instrument at the time, but does not represent exposure to credit, interest rate or market risks.
The table below summarizes the amount of income and losses recognized on the interest rate derivatives designated as cash flow hedges for the three and nine months ended September 30, 2022 and 2021 (amounts in thousands):

Derivatives in Cash Flow Hedging Relationships |  | Amount of Income (Loss) Recognized in Other Comprehensive Income on Derivatives |  | Location of Income (Loss) Reclassified From Accumulated Other Comprehensive Income (Loss) to Net Income |  | Amount of Income (Loss) Reclassified From Accumulated Other Comprehensive Income (Loss) to Net Income |  | Total Amount of Line Item in Condensed Consolidated Statements of Comprehensive Income
Three Months Ended September 30, 2022 |  |  |  |  |  |  |  |
Interest rate swaps - continuing operations |  | $ | 16,724 |  |  | Interest and other expense, net |  | $ | 379 |  |  | $ | 5,498 |
Three Months Ended September 30, 2021 |  |  |  |  |  |  |  |
Interest rate swaps - continuing operations |  | $ | (253) |  |  | Interest and other expense, net |  | $ | (1,952) |  |  | $ | 11,737 |
Interest rate swaps - discontinued operations |  | — |  |  | Income from discontinued operations |  | (542) |  |  | 377,191 |
Total |  | $ | (253) |  |  |  |  | $ | (2,494) |  |  |
Nine Months Ended September 30, 2022 |  |  |  |  |  |  |  |
Interest rate swaps - continuing operations |  | $ | 31,545 |  |  | Interest and other expense, net |  | $ | (2,912) |  |  | $ | 17,942 |
Nine Months Ended September 30, 2021 |  |  |  |  |  |  |  |
Interest rate swaps - continuing operations |  | $ | 2,555 |  |  | Interest and other expense, net |  | $ | (5,643) |  |  | $ | 30,035 |
Interest rate swaps - discontinued operations |  | (37) |  |  | Income from discontinued operations |  | (1,647) |  |  | 401,444 |
Total |  | $ | 2,518 |  |  |  |  | $ | (7,290) |  |  |

Credit Risk-Related Contingent Features
The Company has agreements with each of its derivative counterparties that contain a provision where if the Company either defaults or is capable of being declared in default on any of its indebtedness, then the Company could also be declared in default on its derivative obligations. The Company records credit risk valuation adjustments on its interest rate swaps based on the respective credit quality of the Company and the counterparty. The Company believes it mitigates its credit risk by entering into agreements with creditworthy counterparties. As of September 30, 2022, the Company had no derivatives with fair value in a net liability position, inclusive of accrued interest but excluding any adjustment for nonperformance risk related to the agreement. As of September 30, 2022, there were no termination events or events of default related to the interest rate swaps.
18

Table of Contents
Tabular Disclosure Offsetting Derivatives
The Company has elected not to offset derivative positions in its condensed consolidated financial statements. The following tables present the effect on the Company’s financial position had the Company made the election to offset its derivative positions as of September 30, 2022 and December 31, 2021 (amounts in thousands):

Offsetting of Derivative Assets |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  | Gross Amounts Not Offset in the Balance Sheet |  |
|  | Gross Amounts of Recognized Assets |  | Gross Amounts Offset in the Balance Sheet |  | Net Amounts of Assets Presented in the Balance Sheet |  | Financial Instruments Collateral |  | Cash Collateral |  | Net Amount
September 30, 2022 |  | $ | 29,724 |  |  | $ | — |  |  | $ | 29,724 |  |  | $ | — |  |  | $ | — |  |  | $ | 29,724 |
December 31, 2021 |  | $ | 2,171 |  |  | $ | — |  |  | $ | 2,171 |  |  | $ | (1,023) |  |  | $ | — |  |  | $ | 1,148 |

Offsetting of Derivative Liabilities |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  | Gross Amounts Not Offset in the Balance Sheet |  |
|  | Gross Amounts of Recognized Liabilities |  | Gross Amounts Offset in the Balance Sheet |  | Net Amounts of Liabilities Presented in the Balance Sheet |  | Financial Instruments Collateral |  | Cash Collateral |  | Net Amount
September 30, 2022 |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
December 31, 2021 |  | $ | 5,618 |  |  | $ | — |  |  | $ | 5,618 |  |  | $ | (1,023) |  |  | $ | — |  |  | $ | 4,595 |

Note 13—Stockholders' Equity
Share Repurchase Program
The Company’s Amended and Restated Share Repurchase Program, or SRP, allows for repurchases of shares of the Company’s common stock upon meeting certain criteria. The SRP provides that all repurchases during any calendar year, including those redeemable upon death or a "Qualifying Disability" (as defined in the Company's SRP) of a stockholder, be limited to those that can be funded with equivalent proceeds raised from the DRIP during the prior calendar year and other operating funds, if any, as the Board, in its sole discretion, may reserve for this purpose.
Repurchases of shares of the Company’s common stock are at the sole discretion of the Board, provided, however, that the Company limits the number of shares repurchased during any calendar year to 5.0% of the total number of shares of common stock outstanding as of December 31 st of the previous calendar year. The SRP is subject to terms and limitations, including, but not limited to, quarterly share limitations, an annual 5.0% share limitation and DRIP funding limitations and any amendments to the plan, as more fully described below. In addition, the Board, in its sole discretion, may suspend (in whole or in part) the SRP at any time, and may amend, reduce, terminate or otherwise change the SRP upon 30 days' prior notice to the Company’s stockholders for any reason it deems appropriate.
The Company will currently only repurchase shares due to death and involuntary exigent circumstances in accordance with the SRP, subject in each case to the terms and limitations of the SRP. Under the SRP, the Company may waive certain of the terms and requirements of the SRP in the event of the death of a stockholder who is a natural person, including shares held through an Individual Retirement Account or other retirement or profit-sharing plan, and certain trusts meeting the requirements of the SRP. The Company may also waive certain of the terms and requirements of the SRP in the event of an involuntary exigent circumstance, as determined by the Company or any of the executive officers thereof, in its or their sole discretion. See Part II, Item 2. "Unregistered Sales of Equity Securities" for more information on the Company's SRP.
During the nine months ended September 30, 2022, the Company repurchased 786,861 Class A shares, Class I shares and Class T shares of common stock (690,494 Class A shares, 20,905 Class I shares and 75,462 Class T shares), for an aggregate purchase price of approximately $6,452,000 (an average of $8.20 per share). During the nine months ended September 30, 2021, the Company repurchased 772,581 Class A shares, Class I shares and Class T shares of common stock (715,406 Class A shares, 8,322 Class I shares and 48,853 Class T shares), for an aggregate purchase price of approximately $6,564,000 (an average of $8.50 per share).
19

Table of Contents
Accumulated Other Comprehensive Income (Loss)
The following table presents a rollforward of amounts recognized in accumulated other comprehensive income (loss) by component for the nine months ended September 30, 2022 and 2021 (amounts in thousands):

|  | Unrealized Income on Derivative Instruments
Balance as of December 31, 2021 |  | $ | (4,847) |
Other comprehensive income before reclassification |  | 31,545 |
Amount of loss reclassified from accumulated other comprehensive income (loss) to net income |  | 2,912 |
Other comprehensive income |  | 34,457 |
Balance as of September 30, 2022 |  | $ | 29,610 |

|  | Unrealized Income on Derivative Instruments
Balance as of December 31, 2020 |  | $ | (20,444) |
Other comprehensive income before reclassification |  | 2,518 |
Amount of loss reclassified from accumulated other comprehensive loss to net income |  | 7,290 |
Other comprehensive income |  | 9,808 |
Balance as of September 30, 2021 |  | $ | (10,636) |

The following table presents reclassifications out of accumulated other comprehensive income (loss) for the nine months ended September 30, 2022 and 2021 (amounts in thousands):

Details about Accumulated Other Comprehensive Income (Loss) Components |  | Loss Amounts Reclassified from Accumulated Other Comprehensive Income (Loss) to Net Income |  | Affected Line Items in the Condensed Consolidated Statements of Comprehensive Income
|  | Nine Months Ended September 30, |  |
|  | 2022 |  | 2021 |  |  |  |
Interest rate swap contracts - continuing operations |  | $ | 2,912 |  |  | $ | 5,643 |  |  |  |  | Interest and other expense, net
Interest rate swap contracts - discontinued operations |  | — |  |  | 1,647 |  |  |  |  | Income from discontinued operations
Interest rate swap contracts |  | $ | 2,912 |  |  | $ | 7,290 |  |  |  |  |

Note 14—Earnings Per Share
The Company calculates basic earnings per share by dividing net income attributable to common stockholders for the period by the weighted average shares of its common stock outstanding for that period. Diluted earnings per share is computed based on the weighted average number of shares outstanding and all potentially dilutive securities. Shares of non-vested restricted common stock and Performance DSUs give rise to potentially dilutive shares of common stock. For the three and nine months ended September 30, 2022, diluted earnings per share reflected the effect of approximately 1,319,000 and 1,346,000, respectively, of non-vested shares of restricted common stock and Performance DSUs that were outstanding. For the three and nine months ended September 30, 2021, diluted earnings per share was computed the same as basic earnings per share, because the Company recorded a loss from continuing operations, which would make potentially dilutive shares of 990,000 and 965,000, respectively, related to non-vested shares of restricted common stock and Performance DSUs, anti-dilutive.
20

Table of Contents
Note 15—Stock-based Compensation
On March 6, 2020, the Board approved the Amended and Restated 2014 Restricted Share Plan, or the A&R Incentive Plan, pursuant to which the Company has the authority and power to grant awards of restricted shares of its Class A common stock to its directors, officers and employees. The Company accounts for its stock awards in accordance with ASC 718-10, Compensation—Stock Compensation. ASC 718-10 requires that compensation cost for all stock awards be calculated and amortized over the service period (generally equal to the vesting period). For performance-based awards, compensation costs are recognized over the service period if it is probable that the performance condition will be satisfied, with changes of the assessment at each reporting period and recording the effect of the change in the compensation cost as a cumulative catch-up adjustment. The compensation costs for restricted stock are recognized based on the fair value of the restricted stock awards at grant date less forfeitures (if applicable). Forfeitures are accounted for as they occur.
On January 3, 2022, the Company granted time-based awards to its executive officers, consisting of 217,988 restricted shares of Class A common stock, or the Time-Based 2022 Awards. The Time-Based 2022 Awards will vest ratably over four years following the grant date, subject to each executive's employment through the applicable vesting dates, with certain exceptions.
In addition, on January 3, 2022, the Company's compensation committee approved performance-based deferred stock unit awards, or Performance DSUs, to be granted for performance-based awards, or the Performance-Based 2022 Awards. The Performance-Based 2022 Awards will be measured based on Company performance over a three-year performance period ending on December 31, 2024. The Performance-Based 2022 Awards vest after the last day of the performance period and are subject to continued employment through the applicable vesting date.
The Time-Based 2022 Awards and the Performance-Based 2022 Awards, or collectively, the 2022 Awards, were granted under and are subject to the terms of the A&R Incentive Plan and award agreements.
Stock-based compensation expense for the 2022 Awards for the three and nine months ended September 30, 2022, was approximately $260,000 and $864,000, respectively, which is reported in general and administrative expenses in the accompanying condensed consolidated statements of comprehensive income. The Company recognized accelerated stock-based compensation expense of $326,000 during the nine months ended September 30, 2022. The Company recognized total stock-based compensation expense of approximately $860,000 and $637,000, respectively, for the three months ended September 30, 2022 and 2021, and $3,034,000 and $1,756,000, respectively, for the nine months ended September 30, 2022 and 2021, which is reported in general and administrative expenses in the accompanying condensed consolidated statements of comprehensive income.
Note 16—Commitments and Contingencies
Legal Proceedings
In the ordinary course of business, the Company may become subject to litigation or claims. As of September 30, 2022, there were, and currently there are, no material pending legal proceedings to which the Company is a party. While the resolution of a lawsuit or proceeding may have an impact to the Company's financial results for the period in which it is resolved, the Company believes that the final resolution of the lawsuits or proceedings in which it is currently involved, either individually or in the aggregate, will not have a material adverse effect on its financial position, results of operations or liquidity.
Note 17—Subsequent Events
Distributions Paid to Stockholders
The following table summarizes the Company's distributions paid to stockholders on October 6, 2022, for the period from September 1, 2022 through September 30, 2022 (amounts in thousands):

Payment Date |  | Common Stock |  | Cash |  | DRIP |  | Total Distribution
October 6, 2022 |  | Class A |  | $ | 4,358 |  |  | $ | 1,206 |  |  | $ | 5,564 |
October 6, 2022 |  | Class I |  | 324 |  |  | 224 |  |  | 548 |
October 6, 2022 |  | Class T |  | 716 |  |  | 628 |  |  | 1,344 |
|  |  |  | $ | 5,398 |  |  | $ | 2,058 |  |  | $ | 7,456 |

21

Table of Contents
The following table summarizes the Company's distributions paid to stockholders on November 4, 2022, for the period from October 1, 2022 through October 31, 2022 (amounts in thousands):

Payment Date |  | Common Stock |  | Cash |  | DRIP |  | Total Distribution
November 4, 2022 |  | Class A |  | $ | 4,506 |  |  | $ | 1,249 |  |  | $ | 5,755 |
November 4, 2022 |  | Class I |  | 338 |  |  | 229 |  |  | 567 |
November 4, 2022 |  | Class T |  | 743 |  |  | 648 |  |  | 1,391 |
|  |  |  | $ | 5,587 |  |  | $ | 2,126 |  |  | $ | 7,713 |

Distributions Authorized
The following tables summarize the daily distributions approved and authorized by the Board subsequent to September 30, 2022:

Authorization Date (1) |  | Common Stock |  | Daily Distribution Rate (1) |  | Annualized Distribution Per Share
October 20, 2022 |  | Class A |  | $ | 0.00109589 |  |  | $ | 0.40 |
October 20, 2022 |  | Class I |  | $ | 0.00109589 |  |  | $ | 0.40 |
October 20, 2022 |  | Class T |  | $ | 0.00109589 |  |  | $ | 0.40 |

Authorization Date (2) |  | Common Stock |  | Daily Distribution Rate (2) |  | Annualized Distribution Per Share
November 8, 2022 |  | Class A |  | $ | 0.00109589 |  |  | $ | 0.40 |
November 8, 2022 |  | Class I |  | $ | 0.00109589 |  |  | $ | 0.40 |
November 8, 2022 |  | Class T |  | $ | 0.00109589 |  |  | $ | 0.40 |

(1)Distributions approved and authorized to stockholders of record as of the close of business on each day of the period commencing on November 1, 2022 and ending on November 30, 2022. The distributions are calculated based on 365 days in the calendar year. The distributions declared for each record date in November 2022 will be paid in December 2022. The distributions are payable to stockholders from legally available funds therefor.
(2)Distributions approved and authorized to stockholders of record as of the close of business on each day of the period commencing on December 1, 2022 and ending on December 31, 2022. The distributions will be calculated based on 365 days in the calendar year. The distributions declared for each record date in December 2022 will be paid in January 2023. The distributions will be payable to stockholders from legally available funds therefor.
22

Table of Contents
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and the notes thereto and the other financial information appearing elsewhere in this Quarterly Report on Form 10-Q.
The following discussion should also be read in conjunction with our audited consolidated financial statements, and the notes thereto, and Management's Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the year ended December 31, 2021, as filed with the U.S. Securities and Exchange Commission, or the SEC, on March 29, 2022, or the 2021 Annual Report on Form 10-K.
The terms “we,” “our,” "us," and the “Company” refer to Sila Realty Trust, Inc., Sila Realty Operating Partnership, LP, or our Operating Partnership, and all wholly-owned subsidiaries.
Forward-Looking Statements
Certain statements contained in this Quarterly Report on Form 10-Q, other than historical facts, include forward-looking statements that reflect our expectations and projections about our future results, performance, prospects and opportunities. Such statements include, in particular, our liquidity and capital resources, capital expenditures, material cash requirements, debt service requirements, term loan requirements, plans, leases, dividends, distributions, strategies, and prospects and are subject to certain risks and uncertainties, as well as known and unknown risks, which could cause actual results to differ materially from those projected or anticipated. Therefore, such statements are not intended to be a guarantee of our performance in future periods. Such forward-looking statements can generally be identified by our use of forward-looking terminology such as “may,” “will,” “would,” “could,” “should,” “expect,” “intend,” “anticipate,” “estimate,” “believe,” “continue,” or other similar words. Forward-looking statements are subject to various risks and uncertainties, and factors that could cause actual results to differ materially from our expectations, and investors should not rely on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could materially affect our results of operations, financial condition, cash flows, performance or future achievements or events.
Forward-looking statements that were true at the time made may ultimately prove to be incorrect or false. We make no representation or warranty (express or implied) about the accuracy of any such forward-looking statements contained in this Quarterly Report on Form 10-Q, and we do not undertake to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. See Part I, Item 1A. “Risk Factors” of our 2021 Annual Report on Form 10-K, for a discussion of some, although not all, of the risks and uncertainties that could cause actual results to differ materially from those presented in our forward-looking statements.
Management’s discussion and analysis of financial condition and results of operations is based upon our condensed consolidated financial statements, which have been prepared in accordance with United States generally accepted accounting principles, or GAAP. The preparation of these financial statements requires our management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. We evaluate these estimates on a regular basis. These estimates are based on management’s historical industry experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results may differ from these estimates.
Overview
We invest in high-quality healthcare properties leased to tenants capitalizing on critical and structural economic growth drivers. We are primarily focused on investing in and managing strategic healthcare assets across the continuum of care, with emphasis on lower cost patient settings, which, we believe, typically generate predictable, durable and growing income streams. We may also make other real estate-related investments in healthcare properties, which may include equity or debt interests in other real estate entities.
On July 28, 2020, we and our Operating Partnership entered into a Membership Interest Purchase Agreement to provide for the internalization of the external management functions previously performed for us and our Operating Partnership by our former advisor and its affiliates, or the Internalization Transaction. On September 30, 2020, we closed the Internalization Transaction.
We formerly invested in data center properties. During the three months ended June 30, 2021, our board of directors, or the Board, made a determination to sell our data center properties. On May 19, 2021, we and certain of our wholly-owned subsidiaries entered into a Purchase and Sale Agreement, or the PSA for the sale of up to 29 data center properties owned by us. The Board's determination to sell the data center properties, as well as the execution of the PSA, represented a strategic shift that had a major effect on our results and operations for the periods presented. On July 22, 2021, we completed the sale of our data centers, or the Data Center Sale, comprised of approximately 3,298,000 rentable square feet, for an aggregate sale price of
23

Table of Contents
$1,320,000,000, and generated net proceeds of approximately $1,295,367,000. As of December 31, 2021, we had no assets or liabilities related to the data center segment. The operations of the data center segment have been classified as income from discontinued operations on the condensed consolidated statements of comprehensive income for the three and nine months ended September 30, 2021.
As of September 30, 2022, we owned 132 real estate healthcare properties and two undeveloped land parcels in two µSAs and 56 MSAs.
On August 25, 2022, the Board, at the recommendation of our audit committee, approved the estimated per share net asset value, or Estimated Per Share NAV, calculated as of June 30, 2022, of $8.22. We intend to publish an updated Estimated Per Share NAV on an annual basis.
The Estimated Per Share NAV was calculated for purposes of assisting broker-dealers participating in public offerings in meeting their customer account statement reporting obligations under the National Association of Securities Dealers Conduct Rule 2340. The Estimated Per Share NAV was declared by the Board after consultation with management and an independent third-party valuation firm. The Estimated Per Share NAV is not subject to audit by our independent registered public accounting firm.
We raised the equity capital for our real estate investments through two public offerings, or our Offerings, from May 2014 through November 2018, and we have offered shares pursuant to our distribution reinvestment plan, or the DRIP, pursuant to two Registration Statements on Form S-3, or each, a DRIP Offering and together the DRIP Offerings, since November 2017. As of September 30, 2022, we had accepted investors’ subscriptions for and issued approximately 156,747,000 shares of Class A, Class I, Class T and Class T2 common stock in our Offerings, resulting in receipt of gross proceeds of approximately $1,513,846,000, before share repurchases of approximately $132,936,000, selling commissions and dealer manager fees of approximately $96,734,000 and other offering costs of approximately $27,627,000.
Critical Accounting Estimates
Our critical accounting estimates were disclosed in our 2021 Annual Report on Form 10-K. There have been no material changes to our critical accounting estimates as disclosed therein.
Interim Unaudited Financial Data
Our accompanying condensed consolidated financial statements have been prepared by us in accordance with GAAP in conjunction with the rules and regulations of the SEC. Certain information and footnote disclosures required for annual financial statements have been condensed or excluded pursuant to SEC rules and regulations. Accordingly, our accompanying condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. Our accompanying condensed consolidated financial statements reflect all adjustments, which are, in our view, of a normal recurring nature and necessary for a fair presentation of our financial position, results of operations and cash flows for the interim period. Interim results of operations are not necessarily indicative of the results to be expected for the full year; such full year results may be less favorable. Our accompanying condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto included in our 2021 Annual Report on Form 10-K.
Qualification as a REIT
We elected, and qualify, to be taxed as a REIT for federal income tax purposes and we intend to continue to be taxed as a REIT. To maintain our qualification as a REIT, we must continue to meet certain organizational and operational requirements, including a requirement to distribute at least 90.0% of our REIT taxable income to our stockholders. As a REIT, we generally will not be subject to federal income tax on taxable income that we distribute to our stockholders.
If we fail to maintain our qualification as a REIT in any taxable year, we would then be subject to federal income taxes on our taxable income at regular corporate rates and would not be permitted to qualify for treatment as a REIT for federal income tax purposes for four years following the year during which qualification is lost unless the Internal Revenue Service grants us relief under certain statutory provisions. Such an event could have a material adverse effect on our net income and net cash available for distribution to our stockholders.
Factors That May Influence Results of Operations
We are not aware at this time of any material trends or uncertainties, other than national economic conditions and those discussed below, affecting our real estate properties, that may reasonably be expected to have a material impact, favorable or
24

Table of Contents
unfavorable, on revenues or income from the acquisition, management and operation of our properties other than those set forth in our 2021 Annual Report on Form 10-K.
Rental Revenue
The amount of rental revenue generated by our healthcare properties depends principally on our ability to maintain the occupancy rates of leased space and to lease available space at the then existing rental rates. Negative trends in one or more of these factors could adversely affect our rental revenue in future periods. We continually monitor our tenants' ability to meet their obligations to pay us rent to determine if any adjustments should be reflected currently. Our current financial results have not been adjusted due to any tenants difficulties. As of September 30, 2022, our operating healthcare real estate properties were 99.5% leased.
Results of Operations
The results of operations discussed below reflect the data centers segment presented as discontinued operations.
Our results of operations are influenced by the timing of acquisitions and the performance of our operating healthcare real estate properties. The following table shows the property statistics of our operating healthcare real estate properties as of September 30, 2022 and 2021:

| September 30,
| 2022 |  | 2021
Number of operating real estate properties (1) | 132 |  |  | 124 |
Leased square feet | 5,508,000 |  |  | 5,086,000 |
Weighted average percentage of rentable square feet leased | 99.5 | % |  | 96.0 | %

(1)As of September 30, 2022, we owned 132 operating healthcare real estate properties and two undeveloped land parcels. As of September 30, 2021, we owned 125 healthcare real estate properties, one of which was under construction. As of September 30, 2021, we had three vacant real estate properties that were being marketed for sale or re-tenanting and subsequently sold.
The following table summarizes our healthcare real estate activity for the three and nine months ended September 30, 2022 and 2021:

| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2022 |  | 2021 |  | 2022 |  | 2021
Operating real estate properties acquired | 2 |  |  | — |  |  | 7 |  |  | 1 |
Operating real estate properties placed into service | — |  |  | — |  |  | 1 |  |  | 1 |
Aggregate purchase price of operating real estate properties acquired (1) | $ | 114,744,000 |  |  | $ | — |  |  | $ | 157,194,000 |  |  | $ | 25,048,000 |
Aggregate cost of operating real estate properties placed into service | $ | — |  |  | $ | — |  |  | $ | 15,713,000 |  |  | $ | 22,140,000 |
Leased square feet of operating real estate property additions | 144,449 |  |  | — |  |  | 284,449 |  |  | 115,000 |

(1)Includes capitalized acquisition costs associated with transactions determined to be asset acquisitions.
Same Store Properties
This section describes and compares our results of operations for the three and nine months ended September 30, 2022 and 2021. We generate substantially all of our revenue from property operations. In order to evaluate our overall portfolio, management analyzes the net operating income of same store properties. We define "same store properties" as operating properties that were owned and operated for the entirety of both calendar periods being compared and exclude properties under development and properties or land classified as held for sale.
By evaluating the revenue and expenses of our same store properties, management is able to monitor the operations of our existing properties for comparable periods to measure the performance of our current portfolio and readily observe the expected effects of our new acquisitions and dispositions on net income.
25

Table of Contents
Three Months Ended September 30, 2022 Compared to Three Months Ended September 30, 2021
The following table represents the breakdown of total rental revenue for the three months ended September 30, 2022 compared to the comparable period in 2021 (amounts in thousands).

| Three Months Ended September 30, |  |  |  |
| 2022 |  | 2021 |  | $ Change |  | % Change
Same store rental revenue | $ | 40,844 |  |  | $ | 40,759 |  |  | $ | 85 |  |  | 0.2 | %
Same store tenant reimbursements | 2,498 |  |  | 2,124 |  |  | 374 |  |  | 17.6 | %
Non-same store rental revenue | 3,169 |  |  | 60 |  |  | 3,109 |  |  | 5181.7 | %
Non-same store tenant reimbursements | 370 |  |  | 24 |  |  | 346 |  |  | 1441.7 | %
Other operating income | — |  |  | 96 |  |  | (96) |  |  | (100.0) | %
Total rental revenue | $ | 46,881 |  |  | $ | 43,063 |  |  | $ | 3,818 |  |  | 8.9 | %

•Non-same store rental and tenant reimbursement revenue increased due to the acquisition of ten operating properties and the placement of one development property in service since July 1, 2021, partially offset by a decrease in non-same store rental and tenant reimbursement revenue due to the sale of three operating properties since July 1, 2021.
Changes in our expenses are summarized in the following table (amounts in thousands):

| Three Months Ended September 30, |  |  |  |
| 2022 |  | 2021 |  | $ Change |  | % Change
Same store rental expenses | $ | 2,719 |  |  | $ | 2,565 |  |  | $ | 154 |  |  | 6.0 | %
Non-same store rental expenses | 513 |  |  | 459 |  |  | 54 |  |  | 11.8 | %
General and administrative expenses | 6,118 |  |  | 6,348 |  |  | (230) |  |  | (3.6) | %
Depreciation and amortization | 18,641 |  |  | 17,259 |  |  | 1,382 |  |  | 8.0 | %
Impairment losses | — |  |  | 10,241 |  |  | (10,241) |  |  | (100.0) | %
Total expenses | $ | 27,991 |  |  | $ | 36,872 |  |  | $ | (8,881) |  |  | (24.1) | %

•Non-same store rental expenses increased due to the acquisition of ten operating properties and the placement of one development property in service since July 1, 2021, partially offset by a decrease due to the sale of three operating properties since July 1, 2021.
•General and administrative expenses decreased primarily due to a decrease in corporate legal and transfer agent expenses of approximately $462,000, partially offset by an increase in stock-based compensation of $223,000.
•Depreciation and amortization increased primarily due to the acquisition of ten operating properties and the placement of one development property in service since July 1, 2021, partially offset by a decrease due to the sale of three operating properties since July 1, 2021.
•Impairment loss relates to one healthcare property which occurred during the three months ended September 30, 2021. There were no impairments recorded during the three months ended September 30, 2022.
26

Table of Contents
Changes in interest and other expense, net, are summarized in the following table (amounts in thousands):

| Three Months Ended September 30, |  |  |  |
| 2022 |  | 2021 |  | $ Change |  | % Change
Interest and other expense, net: |  |  |  |  |  |  |
Interest on notes payable | $ | — |  |  | $ | 975 |  |  | $ | (975) |  |  | (100.0) | %
Interest on credit facility | 5,135 |  |  | 5,477 |  |  | (342) |  |  | (6.2) | %
Other expense | 363 |  |  | 5,285 |  |  | (4,922) |  |  | (93.1) | %
Total interest and other expense, net | $ | 5,498 |  |  | $ | 11,737 |  |  | $ | (6,239) |  |  | (53.2) | %
Income from discontinued operations | $ | — |  |  | $ | 377,191 |  |  | $ | (377,191) |  |  | (100.0) | %

•Interest on notes payable decreased due to the repayment of all our notes payable related to healthcare properties on July 22, 2021, with proceeds from the Data Center Sale.
•Interest on credit facility decreased due to a reduction in the weighted average outstanding principal balance on our credit facility of $28 million, which was paid with the proceeds from the Data Center Sale. In addition, we achieved comparably lower interest rates versus the third quarter of 2021, as a result of entering into the Unsecured Credit Facility (as defined below).
•Other expense decreased due to a loss on debt extinguishment related to the repayment of all our healthcare notes payable and a term loan of the prior credit facility with proceeds from the Data Center Sale during the three months ended September 30, 2021, consisting of loan costs of $3,187,000 and accelerated unamortized debt issuance costs of $1,826,000. There was no loss on debt extinguishment during the three months ended September 30, 2022.
•There was no income from discontinued operations during the three months ended September 30, 2022, due to the Data Center Sale in July 2021.
Nine Months Ended September 30, 2022 Compared to Nine Months Ended September 30, 2021
The following table represents the breakdown of total rental revenue for the nine months ended September 30, 2022 compared to the comparable periods in 2021 (amounts in thousands).

| Nine Months Ended September 30, |  |  |  |
| 2022 |  | 2021 |  | $ Change |  | % Change
Same store rental revenue | $ | 119,020 |  |  | $ | 118,932 |  |  | $ | 88 |  |  | 0.1 | %
Same store tenant reimbursements | 7,066 |  |  | 6,609 |  |  | 457 |  |  | 6.9 | %
Non-same store rental revenue | 9,024 |  |  | 3,082 |  |  | 5,942 |  |  | 192.8 | %
Non-same store tenant reimbursements | 969 |  |  | 511 |  |  | 458 |  |  | 89.6 | %
Other operating income | 2 |  |  | 98 |  |  | (96) |  |  | (98.0) | %
Total rental revenue | $ | 136,081 |  |  | $ | 129,232 |  |  | $ | 6,849 |  |  | 5.3 | %

•Non-same store rental revenue increased due to the acquisition of eleven operating properties and the placement of two development properties in service since January 1, 2021, partially offset by a decrease in non-same store rental revenue due to the sale of three operating properties since January 1, 2021.
27

Table of Contents
Changes in our expenses are summarized in the following table (amounts in thousands):

| Nine Months Ended September 30, |  |  |  |
| 2022 |  | 2021 |  | $ Change |  | % Change
Same store rental expenses | $ | 7,915 |  |  | $ | 7,811 |  |  | $ | 104 |  |  | 1.3 | %
Non-same store rental expenses | 1,352 |  |  | 1,702 |  |  | (350) |  |  | (20.6) | %
General and administrative expenses | 20,718 |  |  | 19,610 |  |  | 1,108 |  |  | 5.7 | %
Depreciation and amortization | 54,443 |  |  | 53,098 |  |  | 1,345 |  |  | 2.5 | %
Impairment losses | 7,387 |  |  | 27,837 |  |  | (20,450) |  |  | (73.5) | %
Total expenses | $ | 91,815 |  |  | $ | 110,058 |  |  | $ | (18,243) |  |  | (16.6) | %
Gain on real estate dispositions | $ | 460 |  |  | $ | — |  |  | $ | 460 |  |  | 100.0 | %

•Non-same store rental expenses decreased due to the sale of three operating properties since January 1, 2021, which were vacant prior to sale, thus requiring us to incur incrementally more expenses.
•General and administrative expenses increased primarily due to a severance payment to our former chief accounting officer and an increase in stock-based compensation, partially offset by a decrease in corporate legal and transfer agent expenses.
•Depreciation and amortization increased primarily due to the acquisition of eleven operating properties and the placement of two development properties in service since January 1, 2021, coupled with an impairment of one in-place lease intangible asset in the amount of approximately $380,000 during the nine months ended September 30, 2022, related to a healthcare tenant. The increase was partially offset by an impairment of one in-place lease intangible asset during the nine months ended September 30, 2021, in the amount of approximately $1,120,000 related to one of our healthcare tenants and the sale of three operating properties since January 1, 2021.
•Impairment losses were recorded in the aggregate amount of $7,387,000 related to one healthcare property during the nine months ended September 30, 2022. Impairment losses were recorded in the aggregate amount of $27,837,000 related to one healthcare property and one land parcel that formerly contained a healthcare property during the nine months ended September 30, 2021.
Changes in interest and other expense, net, are summarized in the following table (amounts in thousands):

| Nine Months Ended September 30, |  |  |  |
| 2022 |  | 2021 |  | $ Change |  | % Change
Interest and other expense, net: |  |  |  |  |  |  |
Interest on notes payable | $ | — |  |  | $ | 4,630 |  |  | $ | (4,630) |  |  | (100.0) | %
Interest on credit facility | 13,553 |  |  | 19,931 |  |  | (6,378) |  |  | (32.0) | %
Other expense | 4,389 |  |  | 5,474 |  |  | (1,085) |  |  | (19.8) | %
Total interest and other expense, net | $ | 17,942 |  |  | $ | 30,035 |  |  | $ | (12,093) |  |  | (40.3) | %
Income from discontinued operations | $ | — |  |  | $ | 401,444 |  |  | $ | (401,444) |  |  | (100.0) | %

•Interest on notes payable decreased due to the repayment of all our notes payable related to healthcare properties on July 22, 2021, with proceeds from the Data Center Sale.
•Interest on credit facility decreased due to a reduction in the weighted average outstanding principal balance on our credit facility of $307 million, which was paid with the proceeds from the Data Center Sale. In addition, we achieved comparably lower interest rates versus the nine months ended September 30, 2021, as a result of entering into the Unsecured Credit Facility (as defined below).
•Other expense decreased due to a loss on debt extinguishment related to the repayment of all our healthcare notes payable and a term loan of the prior credit facility with proceeds from the Data Center Sale during the nine months ended September 30, 2021, consisting of loan costs of $3,187,000 and accelerated unamortized debt issuance costs of $1,826,000, partially offset by loss on debt extinguishment recorded during the nine months ended September 30, 2022, related to the repayment of our prior credit facility consisting primarily of accelerated unamortized debt issuance costs of $3,363,000.
•There was no income from discontinued operations during the nine months ended September 30, 2022, due to the Data Center Sale in July 2021.
28

Table of Contents
Liquidity and Capital Resources
Our principal uses of funds are for acquisitions of real estate and real estate-related investments, capital expenditures, operating expenses, distributions to and share repurchases from stockholders and principal and interest payments on any current and future indebtedness. While interest rates on variable rate debt have increased and we expect will continue to increase globally, we believe our exposure is limited at this time due to our hedging strategy, which has effectively fixed 81% of our outstanding debt as of September 30, 2022, allowing us to reasonably project our cash needs. Generally, cash for these items is generated from operations of our current and future investments. Our sources of funds are primarily operating cash flows, funds equal to amounts reinvested in the DRIP, our credit facility and other potential borrowings.
When we acquire a property, we prepare a capital plan that contemplates the estimated capital needs of that investment. In addition to operating expenses, capital needs may also include, for example, costs of refurbishment, tenant improvements or other major capital expenditures. The capital plan also sets forth the anticipated sources of the necessary capital, which may include a line of credit, operating cash generated by the investment, additional equity investments from us, and when necessary, capital reserves. The capital plan for each investment will be adjusted through ongoing, regular reviews of our portfolio or, as necessary, to respond to unanticipated additional capital needs.
Short-term Liquidity and Capital Resources
For at least the next twelve months, we expect our principal demands for funds will be for operating expenses, including our general and administrative expenses, as well as the acquisition of real estate and real estate-related investments and funding of capital improvements and tenant improvements, distributions to and repurchases from stockholders, and interest payments on our credit facility. We expect to meet our short-term liquidity requirements through net cash flows provided by operations, funds equal to amounts reinvested in the DRIP and borrowings on our credit facility and potential other borrowings.
We believe we will have sufficient liquidity available to meet our obligations in a timely manner, under both normal and stressed conditions, for the next twelve months.
Long-term Liquidity and Capital Resources
Beyond the next twelve months, we expect our principal demands for funds will be for costs to acquire additional real estate properties, interest and principal payments on our credit facility, long-term capital investment demands for our real estate properties and our distributions necessary to maintain our REIT status.
We currently expect to meet our long-term liquidity requirements through proceeds from cash flows from operations and borrowings on our credit facility and potential other borrowings.
We expect to pay distributions to our stockholders from cash flows from operations; however, we have used, and may continue to use, other sources to fund distributions, as necessary, such as funds equal to amounts reinvested in the DRIP and borrowings on our credit facility. To the extent cash flows from operations are lower due to less-than-expected returns on the properties held or the disposition of properties, distributions paid to stockholders may be lower. We currently expect that substantially all net cash flows from our operations will be used to fund acquisitions, certain capital expenditures identified at acquisition, ongoing capital expenditures, interest and principal payments on outstanding debt and distributions to our stockholders.
Material Cash Requirements
In addition to the cash we need to conduct our normal business operations, we expect to require approximately $21,733,000 in cash over the next twelve months, of which $19,073,000 will be required for the payment of estimated interest on our outstanding debt (calculated based on our effective interest rates as of September 30, 2022) and $2,660,000 related to our various obligations as lessee. We cannot provide assurances, however, that actual expenditures will not exceed these estimates.
As of September 30, 2022, we had approximately $17,291,000 in cash and cash equivalents. For the nine months ended September 30, 2022, we paid capital expenditures of $7,577,000 that primarily related to the completion of one development property, which was placed into service during the period, and re-developing another operating real estate property.
As of September 30, 2022, we had material obligations beyond 12 months in the amount of approximately $778,396,000, inclusive of $659,358,000 related to principal and estimated interest payments on our outstanding debt (calculated based on our effective interest rates as of September 30, 2022) and $119,038,000 related to our various obligations as lessee.
One of our principal liquidity needs is the payment of principal and interest on outstanding indebtedness. As of September 30, 2022, we had $600,000,000 of principal outstanding under our Unsecured Credit Facility (as defined below). We are required by the terms of certain loan documents to meet certain covenants, such as financial ratios and reporting requirements.
29

Table of Contents
As of September 30, 2022, we were in compliance with all such covenants and requirements on our Unsecured Credit Facility (as defined below).
As of September 30, 2022, the aggregate notional amount under our derivative instruments was $485,000,000. We have agreements with each derivative counterparty that contain cross-default provisions; if we default on our indebtedness, then we could also be declared in default on our derivative obligations, resulting in an acceleration of payment of any net amounts due under our derivative contracts. As of September 30, 2022, we were in compliance with all such cross-default provisions.
Debt Service Requirements
Credit Facility
As of September 30, 2022, the maximum commitments available under our senior unsecured revolving line of credit with Truist Bank, as Administrative Agent for the lenders, or the Revolving Credit Agreement, were $500,000,000, which may be increased, subject to lender approval, through incremental term loans and/or revolving loan commitments in an aggregate amount not to exceed $1,000,000,000. The maturity date for the Revolving Credit Agreement is February 15, 2026, which, at our election, may be extended for a period of six-months on no more than two occasions, subject to certain conditions, including the payment of an extension fee. The Revolving Credit Agreement was entered into on February 15, 2022, to replace our prior $500,000,000 revolving line of credit, which had a maturity date of April 27, 2022, with the option to extend for one twelve-month period. We did not exercise the option to extend. Upon closing of the Revolving Credit Agreement, we extinguished all commitments associated with the prior revolving line of credit.
As of September 30, 2022, the maximum commitments available under our senior unsecured term loan with Truist Bank, as Administrative Agent for the lenders, or the 2024 Term Loan Agreement, were $300,000,000, which may be increased, subject to lender approval, to an aggregate amount not to exceed $600,000,000. The 2024 Term Loan Agreement has a maturity date of December 31, 2024, and, at our election, may be extended for a period of six-months on no more than two occasions, subject to the satisfaction of certain conditions, including the payment of an extension fee. The 2024 Term Loan Agreement was entered into simultaneously with the Revolving Credit Agreement’s execution, on February 15, 2022, to replace our prior term loan, which was paid off in its entirety upon closing of the Revolving Credit Agreement and the 2024 Term Loan Agreement.
As of September 30, 2022, the maximum commitments available under our senior unsecured term loan with Truist Bank, as Administrative Agent for the lenders, or the 2028 Term Loan Agreement, were $275,000,000, of which $205,000,000 was drawn at closing to pay down our Revolving Credit Agreement in its entirety. The remainder of the commitments were available for three months following the closing date, or the Availability Period, and were available in no more than three subsequent draws with a minimum of $20,000,000 per draw, or the remaining commitments available. After the Availability Period, the undrawn portion was no longer available. If the committed amount was not fully drawn within 60 days of closing, we were required to pay a fee to the lenders, calculated as 0.25% per annum on the average daily amount of the undrawn portion, payable quarterly in arrears, until the earlier of (i) the date when the commitments have been funded in full, or (ii) August 17, 2022. The 2028 Term Loan Agreement may be increased, subject to lender approval, to an aggregate amount not to exceed $500,000,000 and has a maturity date of January 31, 2028. The 2028 Term Loan Agreement is pari passu with our Revolving Credit Agreement and 2024 Term Loan Agreement. On July 12, 2022 and July 20, 2022, we drew $50,000,000 and $20,000,000, respectively, on the 2028 Term Loan Agreement. As of July 20, 2022, the 2028 Term Loan Agreement commitments were fully funded.
We refer to the 2028 Term Loan Agreement, the Revolving Credit Agreement and the 2024 Term Loan Agreement, collectively, as the “Unsecured Credit Facility,” which has aggregate commitments available of $1,075,000,000, as of September 30, 2022. Generally, the proceeds of loans made under our Unsecured Credit Facility may be used for the acquisition of real estate investments, tenant improvements and leasing commissions with respect to real estate, repayment of indebtedness, capital expenditures with respect to real estate, and general corporate and working capital purposes.
During the nine months ended September 30, 2022, we drew $70,000,000 on the Revolving Credit Agreement related to seven property acquisitions and we repaid $40,000,000 on the Revolving Credit Agreement, with proceeds from one property disposition and cash flows from operations.
As of September 30, 2022, we had a total pool availability under our Unsecured Credit Facility of $1,075,000,000 and an aggregate outstanding principal balance of $600,000,000; therefore, $475,000,000 was available to be drawn under our Unsecured Credit Facility. We were in compliance with all financial covenant requirements as of September 30, 2022.
30

Table of Contents
Cash Flows
Nine Months Ended September 30, 2022 Compared to Nine Months Ended September 30, 2021

| Nine Months Ended September 30, |  |  |  |
(in thousands) | 2022 |  | 2021 |  | Change |  | % Change
Net cash provided by operating activities | $ | 89,031 |  |  | $ | 104,816 |  |  | $ | (15,785) |  |  | (15.1) | %
Net cash (used in) provided by investing activities | $ | (141,949) |  |  | $ | 1,263,096 |  |  | $ | (1,405,045) |  |  | (111.2) | %
Net cash provided by (used in) financing activities | $ | 37,495 |  |  | $ | (1,359,616) |  |  | $ | 1,397,111 |  |  | (102.8) | %

Cash flows from discontinued operations are not separately disclosed on the condensed consolidated statement of cash flows for the nine months ended September 30, 2021.
Operating Activities
•Net cash provided by operating activities decreased primarily due to the Company owning fewer properties subsequent to the Data Center Sale on July 22, 2021, partially offset by an increase in rental revenues resulting from the acquisition of eleven operating properties and placement of two development properties in service since January 1, 2021 and a decrease in interest paid as a result of entering into the Unsecured Credit Facility and the pay-off of all our notes payable on July 22, 2021, in connection with the Data Center Sale.
Investing Activities
•Net cash used in investing activities for the nine months ended September 30, 2022, was due to the purchase of operating real estate properties and payment of capital expenditures primarily related to the completion of one development property, which was placed into service during the period, and re-developing another operating real estate property, partially offset by proceeds from the sale of one property. Net cash provided by investing activities for the nine months ended September 30, 2021, was primarily due to the Data Center Sale and the collection of a note receivable, partially offset by the purchase of one real estate property, payment of capital expenditures related to one data center property and three healthcare properties and consideration paid for the Internalization Transaction.
Financing Activities
•Net cash provided by financing activities for the nine months ended September 30, 2022, was due to proceeds from our credit facility, partially offset by payments on our credit facility, payments of deferred financing costs as a result of entering into the 2024 Term Loan Agreement and Revolving Credit Agreement on February 15, 2022 and the 2028 Term Loan Agreement on May 17, 2022, repurchases of our common stock under our share repurchase program, distributions to our common stockholders and payment of offering costs on issuance of common stock. Net cash used in financing activities for the nine months ended September 30, 2021, was due to payments on notes payable and debt extinguishment as a result of the Data Center Sale, payments on our credit facility primarily with proceeds from the Data Center Sale, payments of deferred financing costs, repurchases of our common stock under our share repurchase program, distributions to our common stockholders, including a special cash distribution, and payment of offering costs on issuance of common stock, partially offset by proceeds from our credit facility.
Distributions to Stockholders
The amount of distributions payable to our stockholders is determined by the Board and is dependent on a number of factors, including our funds available for distribution, financial condition, lenders' restrictions and limitations, capital expenditure requirements, corporate law restrictions and the annual distribution requirements needed to maintain our status as a REIT under the Internal Revenue Code of 1986, as amended. The Board must authorize each distribution and may, in the future, authorize lower amounts of distributions or not authorize additional distributions and, therefore, distribution payments are not guaranteed. Additionally, our organizational documents permit us to pay distributions from unlimited amounts of any source, and we may use sources other than operating cash flows to fund distributions, including funds equal to amounts reinvested in the DRIP, which may reduce the amount of capital we ultimately invest in properties or other permitted investments. We have funded distributions with operating cash flows from our properties and funds equal to amounts reinvested in the DRIP. To the extent that we do not have taxable income, distributions paid will be considered a return of capital to stockholders.
31

Table of Contents
The following table shows the sources of distributions paid during the nine months ended September 30, 2022 and 2021 (amounts in thousands):

| Nine Months Ended September 30, |
| 2022 |  | 2021 |
Distributions paid in cash - common stockholders | $ | 48,920 |  |  |  |  | $ | 450,143 |  | (1) |  |
Distributions reinvested (shares issued) | 18,594 |  |  |  |  | 21,750 |  |  |  |
Total distributions | $ | 67,514 |  |  |  |  | $ | 471,893 |  |  |  |
Source of distributions: |  |  |  |  |  |  |  |
Cash flows provided by operations | $ | 48,920 |  |  | 72 | % | (2) | $ | 57,458 |  |  | 12 | % | (2)
Offering proceeds from issuance of common stock pursuant to the DRIP | 18,594 |  |  | 28 | % | (2) | 21,750 |  |  | 5 | % | (2)
Proceeds from real estate disposals | — |  |  | — | % | (2) | 392,685 |  |  | 83 | % | (2)
Total sources | $ | 67,514 |  |  | 100 | % |  | $ | 471,893 |  |  | 100 | % |

(1)Includes a special cash distribution declared by the Board of $1.75 per share of Class A, Class I, Class T and Class T2 common stock. The special cash distribution was funded with the proceeds from the Data Center Sale on July 22, 2021. The special cash distribution was paid on July 30, 2021, to stockholders of record at the close of business on July 26, 2021, in the aggregate amount of approximately $392,685,000.
(2)Percentages were calculated by dividing the respective source amount by the total sources of distributions.
Total distributions declared but not paid on Class A shares, Class I shares and Class T shares as of September 30, 2022, were approximately $7,456,000 for common stockholders. These distributions were paid on October 6, 2022.
For the nine months ended September 30, 2022, we declared and paid distributions of approximately $67,514,000 to Class A stockholders, Class I stockholders, Class T stockholders and Class T2 stockholders, collectively, including shares issued pursuant to the DRIP, as compared to FFO and AFFO (which are Non-GAAP measures defined and reconciled below under "Non-GAAP Financial Measures") for the nine months ended September 30, 2022, of approximately $88,080,000 and $90,096,000, respectively.
Non-GAAP Financial Measures
In the real estate industry, analysts and investors employ certain non-GAAP supplemental financial measures in order to facilitate meaningful comparisons between periods and among peer companies. Additionally, in the formulation of our goals and in the evaluation of the effectiveness of our strategies, we use funds from operations, or FFO, and adjusted funds from operations, or AFFO, which are non-GAAP metrics. We believe that these measures are useful to investors to consider because they may assist them to better understand and measure the performance of our business over time and against similar companies.
A description of FFO and AFFO and reconciliations of these non-GAAP measures to the most directly comparable GAAP measures, are provided below.
Funds from Operations and Adjusted Funds from Operations
One of our objectives is to provide cash distributions to our stockholders from cash flows generated by our operations. The purchase of real estate assets and real estate-related investments, and the corresponding expenses associated with that process, is a key operational function of our business plan in order to generate cash flows from operations. Due to certain unique operating characteristics of real estate companies, the National Association of Real Estate Investment Trusts, or NAREIT, an industry trade group, has promulgated a measure known as FFO, which we believe is an appropriate supplemental measure to reflect the operating performance of a REIT. The use of FFO is recommended by the REIT industry as a supplemental performance measure. FFO is not equivalent to our net income as determined under GAAP.
We define FFO, consistent with NAREIT’s definition, as net income (loss) (calculated in accordance with GAAP), excluding gains (or losses) from sales of real estate assets and impairments of real estate assets, plus depreciation and amortization of real estate assets, and after adjustments for unconsolidated partnerships and joint ventures. Adjustments for unconsolidated partnerships and joint ventures will be calculated to reflect FFO on the same basis. To date, we have not had any investments in unconsolidated partnerships or joint ventures.
We, along with our peers in the real estate industry, consider FFO to be an appropriate supplemental measure of a REIT’s operating performance, because it is based on a net income (loss) analysis of real estate portfolio performance that excludes non-cash items such as real estate depreciation and amortization and real estate impairments, which we believe provides a more
32

Table of Contents
complete understanding of our performance to the investors and to our management, and when compared to year over year, FFO reflects the impact on our operations from trends in occupancy.
We calculate AFFO, a non-GAAP measure, by further adjusting FFO for the following items included in the determination of GAAP net income: amortization of above- and below-market leases, amortization of operating leases and the finance lease, straight-line rent adjustments, deferred rent, discount amortization related to the deferred liability in connection with the Internalization Transaction, (gain) loss on extinguishment of debt, amortization of deferred financing costs and stock-based compensation. By excluding such charges that may reflect anticipated and unrealized gains or losses, we believe AFFO provides useful supplemental information.
AFFO is a metric used by management to evaluate our dividend policy. Additionally, we consider AFFO to be an appropriate supplemental measure of our operating performance because it provides to investors a more complete understanding of our sustainable performance.
Presentation of this information is intended to assist management and investors in comparing the operating performance of different REITs, although it should be noted that not all REITs calculate FFO and AFFO the same way, so comparisons with other REITs may not be meaningful. Furthermore, FFO and AFFO are not necessarily indicative of cash flows available to fund cash needs and should not be considered as an alternative to net income as an indication of our performance, as an indication of our liquidity, or indicative of funds available for our cash needs, including our ability to make distributions to our stockholders. FFO and AFFO should be reviewed in conjunction with other measurements as an indication of our performance. FFO and AFFO have limitations as performance measures. However, FFO and AFFO may be useful in assisting management and investors in assessing the sustainability of operating performance in future operating periods. FFO and AFFO are not useful measures in evaluating net asset value since impairments are taken into account in determining net asset value but not in determining FFO and AFFO.
FFO and AFFO, as described above, should not be considered to be more relevant or accurate than the GAAP methodology in calculating net income or in its applicability in evaluating our operational performance. The method used to evaluate the value and performance of real estate under GAAP should be considered as a more relevant measure of operating performance and considered more prominent than the non-GAAP FFO and AFFO measures and the adjustments to GAAP in calculating FFO and AFFO.
Reconciliation of FFO and AFFO
The following is a reconciliation of net income attributable to common stockholders, which is the most directly comparable GAAP financial measure, to FFO and AFFO for the three and nine months ended September 30, 2022 and 2021 (amounts in thousands):

| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2022 |  | 2021 |  | 2022 |  | 2021
Net income attributable to common stockholders | $ | 13,392 |  |  | $ | 371,645 |  |  | $ | 26,784 |  |  | $ | 390,583 |
Adjustments: |  |  |  |  |  |  |
Depreciation and amortization | 18,615 |  |  | 17,289 |  |  | 54,369 |  |  | 64,843 |
Gain on real estate disposition from continuing operations | — |  |  | — |  |  | (460) |  |  | — |
Gain on real estate dispositions from discontinued operations | — |  |  | (398,560) |  |  | — |  |  | (395,801) |
Impairment losses | — |  |  | 10,241 |  |  | 7,387 |  |  | 27,837 |
FFO attributable to common stockholders | $ | 32,007 |  |  | $ | 615 |  |  | $ | 88,080 |  |  | $ | 87,462 |
Adjustments: |  |  |  |  |  |  |
Amortization of above- and below-market leases | 122 |  |  | 13 |  |  | 362 |  |  | (1,239) |
Amortization of operating leases and finance lease | 193 |  |  | 189 |  |  | 719 |  |  | 674 |
Straight-line rent adjustments | (2,589) |  |  | (3,414) |  |  | (7,530) |  |  | (12,492) |
Deferred rent | 299 |  |  | — |  |  | 797 |  |  | — |
Amortization of discount of deferred liability | — |  |  | 163 |  |  | — |  |  | 272 |
Loss on extinguishment of debt | — |  |  | 28,751 |  |  | 3,367 |  |  | 28,751 |
Amortization of deferred financing costs | 413 |  |  | 754 |  |  | 1,267 |  |  | 2,761 |
Stock-based compensation | 860 |  |  | 637 |  |  | 3,034 |  |  | 1,756 |
AFFO attributable to common stockholders | $ | 31,305 |  |  | $ | 27,708 |  |  | $ | 90,096 |  |  | $ | 107,945 |

33

Table of Contents
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
Market risk includes risks that arise from changes in interest rates, foreign currency exchange rates, commodity prices, equity prices and other market changes that affect market sensitive instruments. In pursuing our business plan, the primary market risk to which we are exposed is interest rate risk.
We have obtained variable rate debt financing to fund certain property acquisitions and we are exposed to such changes in the one-month Term SOFR (as defined below). Our objectives in managing interest rate risk are to seek to limit the impact of interest rate fluctuations on operations and cash flows, and to lower overall borrowing costs. To achieve these objectives, we will borrow primarily at interest rates with the lowest margins available and, in some cases, with the ability to convert variable interest rates to fixed rates.
In July 2017, the Financial Conduct Authority, or FCA, which regulates LIBOR, announced it intends to stop compelling banks to submit rates for the calculation of LIBOR after 2021. As a result, the Federal Reserve Board and the Federal Reserve Bank of New York organized the Alternative Reference Rates Committee which identified the Secured Overnight Financing Rate, or SOFR, as its preferred alternative to USD-LIBOR in derivatives and other financial contracts. Subsequently, on March 5, 2021, the FCA announced that USD-LIBOR will no longer be published after June 30, 2023. Effective February 15, 2022, we have no LIBOR-rate debt. Loans under the Unsecured Credit Facility may be made as Base Rate Loans or SOFR Loans, at our election. On May 2, 2022, we entered into bilateral agreements with our swap counterparties to transition all of our swap agreements to SOFR.
As of September 30, 2022, we had 12 interest rate swap agreements outstanding, which mature on various dates from April 2023 to January 2028, with an aggregate notional amount under the swap agreements of $485,000,000. Of the 12 interest rate swap agreements outstanding, three interest rate swap agreements with an aggregate notional amount of $150,000,000 have an effective date of May 1, 2023, and will replace two interest rate swaps with an aggregate notional amount of $150,000,000 that have a maturity date of April 27, 2023. As of September 30, 2022, the aggregate settlement asset value was $30,378,000. The settlement value of these interest rate swap agreements is dependent upon existing market interest rates and swap spreads. As of September 30, 2022, an increase of 50 basis points in the market rates of interest would have resulted in an increase to the settlement asset value of these interest rate swaps to a value of $38,023,000. These interest rate swap agreements were designated as hedging instruments.
On April 8, 2022, we entered into two interest rate swap agreements, which have an effective date of May 2, 2022 and an aggregate notional amount of $85,000,000.
As of September 30, 2022, of the $600,000,000 total principal debt outstanding, $115,000,000 was subject to variable interest rates, indexed to Term SOFR, with an interest rate of 3.9% per annum. As of September 30, 2022, an increase of 50 basis points in the market rates of interest would have resulted in an increase in interest expense of approximately $575,000 per year.
We have entered, and may continue to enter, into additional derivative financial instruments, such as interest rate swaps, in order to mitigate our interest rate risk on a given variable rate financial instrument. To the extent we do, we are exposed to credit risk and market risk. Credit risk is the failure of the counterparty to perform under the terms of the derivative contract. When the fair value of a derivative contract is positive, the counterparty owes us, which creates credit risk for us. When the fair value of a derivative contract is negative, we owe the counterparty and, therefore, it does not possess credit risk. Market risk is the adverse effect on the value of a financial instrument that results from a change in interest rates. We manage the market risk associated with interest rate contracts by establishing and monitoring parameters that limit the types and degree of market risk that may be undertaken. We have not entered, and do not intend to enter, into derivative or interest rate transactions for speculative purposes. We may also enter into rate-lock arrangements to lock interest rates on future borrowings.
In addition to changes in interest rates, the value of our future investments will be subject to fluctuations based on changes in local and regional economic conditions and changes in the creditworthiness of tenants, which may affect our ability to refinance our debt, if necessary.
We do not have any foreign operations and thus we are not exposed to foreign currency fluctuations.
34

Table of Contents
The following table summarizes our principal debt outstanding related to our credit facility as of September 30, 2022 (amounts in thousands):

| September 30, 2022
Variable rate revolving line of credit | $ | 25,000 |
Variable rate term loans fixed through interest rate swaps | 485,000 |
Variable rate term loans | 90,000 |
Total principal debt outstanding (1) | $ | 600,000 |

(1)As of September 30, 2022, the weighted average interest rate on our total debt outstanding was 3.1%.
Item 4. Controls and Procedures.
(a) Evaluation of disclosure controls and procedures. We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports pursuant to the Securities Exchange Act of 1934, as amended, or the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the rules and forms, and that such information is accumulated and communicated to us, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, we recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, as ours are designed to do, and we necessarily were required to apply our judgment in evaluating whether the benefits of the controls and procedures that we adopt outweigh their costs.
As required by Rules 13a-15(b) and 15d-15(b) of the Exchange Act, we conducted an evaluation as of September 30, 2022, under the supervision and with the participation of our management, including our chief executive officer and chief financial officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on this evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures, as of September 30, 2022, were effective at a reasonable assurance level.
(b) Changes in internal control over financial reporting. There have been no changes in our internal controls over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that occurred during the three months ended September 30, 2022, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
35

Table of Contents
PART II. OTHER INFORMATION
Item 1. Legal Proceedings.
We are not aware of any material pending legal proceedings to which we are a party or to which our properties are the subject.
Item 1A. Risk Factors
There have been no material changes from the risk factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2021, as filed with the SEC on March 29, 2022.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
Unregistered Sales of Equity Securities
On July 1, 2022, we granted an aggregate of 54,878.05 shares of restricted Class A common stock to our five independent directors. Each independent director received 10,975.61 shares of restricted Class A common stock that vest on July 1, 2023. The awards were granted under and subject to the terms of our Amended and Restated 2014 Restricted Share Plan and an award agreement.
On August 3, 2022, we granted our new chief accounting officer an award of 42,682.927 shares of restricted Class A common stock, which, subject to the chief accounting officer's continuous employment through the applicable vesting date, with certain exceptions, will vest on January 1, 2027. The award was granted under and subject to the terms of the Amended and Restated 2014 Restricted Share Plan and an award agreement.
During the three months ended September 30, 2022, we fulfilled the following repurchase requests pursuant to our Share Repurchase Program:

Period |  | Total Number of Shares Repurchased |  | Average Price Paid per Share |  | Total Number of Shares Purchased as Part of Publicly Announced Plans and Programs |  | Approximate Dollar Value of Shares Available that may yet be Repurchased under the Program
July 1, 2022 - July 31, 2022 |  | 225,136 |  |  | $ | 8.20 |  |  | — |  |  | $ | — |
August 1, 2022 - August 31, 2022 |  | — |  |  | $ | — |  |  | — |  |  | $ | — |
September 1, 2022 - September 30, 2022 |  | — |  |  | $ | — |  |  | — |  |  | $ | — |
Total |  | 225,136 |  |  |  |  | — |  |  |

During the three months ended September 30, 2022, we repurchased approximately $1,846,000 of Class A shares, Class I shares and Class T shares of common stock.
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosures.
Not applicable.
Item 5. Other Information.
None.
36

Table of Contents
Item 6. Exhibits.
Effective September 30, 2020, Carter Validus Mission Critical REIT II, Inc., Carter Validus Operating Partnership II, LP, CVMC REIT II, LLC, CVOP Partner, LLC, Carter/Validus Operating Partnership, LP and CV Manager, LLC changed their names to Sila Realty Trust, Inc., Sila Realty Operating Partnership, LP, Sila REIT, LLC, Sila Partner, LLC, Sila Operating Partnership, LP and Sila Realty Management Company, LLC, respectively. With respect to documents executed prior to the name change, the following Exhibit List refers to the entity names used prior to the name changes in order to accurately reflect the names of the entities that appear on such documents.

Exhibit No: |  |
3.1 |  | Second Articles of Amendment and Restatement of Carter Validus Mission Critical REIT II, Inc. (included as Exhibit 3.1 to Post-Effective Amendment No. 1 to the Registrant’s Registration Statement on Form S-11 (File No. 333-191706) filed June 12, 2014, and incorporated herein by reference).
3.2 |  | Amended and Restated Bylaws of Carter Validus Mission Critical REIT II, Inc. (included as Exhibit 3.2 to Pre-Effective Amendment No. 3 to the Registrant’s Registration Statement on Form S-11 (File No. 333-191706) filed May 9, 2014, and incorporated herein by reference).
3.3 |  | Articles Supplementary of Carter Validus Mission Critical REIT II, Inc., filed on January 13, 2017 (included as Exhibit 3.1 to the Registrant's Current Report on Form 8-K (File No. 000-55435) filed on January 18, 2017, and incorporated herein by reference).
3.4 |  | Articles Supplementary of Carter Validus Mission Critical REIT II, Inc., filed on June 2, 2017 (included as Exhibit 3.1 to the Registrant's Current Report on Form 8-K (File No. 000-55435) filed on June 6, 2017, and incorporated herein by reference.
3.5 |  | Articles of Amendment of Carter Validus Mission Critical REIT II, Inc., filed on August 18, 2017 (included as Exhibit 3.1 to the Registrant's Current Report on Form 8-K (File No. 000-55435) filed on August 22, 2017, and incorporated herein by reference).
3.6 |  | Certificate of Correction to the Articles Supplementary of Carter Validus Mission Critical REIT II, Inc. (included as Exhibit 3.1 to the Registrant's Current Report on Form 8-K (File No. 000-55435) filed on July 2, 2018, and incorporated herein by reference).
3.7 |  | Articles of Amendment of Carter Validus Mission Critical REIT II, Inc., dated December 12, 2019 (included as Exhibit 3.1 to the Registrant's Current Report on Form 8-K (File No. 000-55435) filed on December 12, 2019, and incorporated herein by reference).
3.8 |  | Articles of Amendment (included as Exhibit 3.1 to the Registrant's Current Report on Form 8-K (File No. 000-55435) filed on September 30, 2020, and incorporated herein by reference).
3.9 |  | Third Articles of Amendment and Restatement (included as Exhibit 3.1 to the Registrant's Current Report on Form 8-K (File No. 000-55435) filed on August 15, 2022, and incorporated herein by reference).
4.1 |  | Subscription Agreement and Subscription Agreement Signature Page (included as Appendix B to the prospectus, incorporated by reference to the Registrant's final prospectus filed pursuant to Rule 424(b)(3), filed on November 27, 2017 (File No. 333-217579)).
4.2 |  | Additional Subscription Agreement and Subscription Agreement Signature Page (included as Appendix C to the prospectus. incorporated by reference to the Registrant's final prospectus filed pursuant to Rule 424(b)(3), filed on November 27. 2017 (File No. 333-217579)).
4.3 |  | Automatic Purchase Program Enrollment Form (included as Appendix D to the prospectus, incorporated by reference to the Registrant's final prospectus filed pursuant to Rule 424(b)(3), filed on November 27, 2017, and incorporated herein by reference).
4.4 |  | Third Amended and Restated Distribution Reinvestment Plan (included as Appendix E to the prospectus attached to Post-Effective Amendment No. 11 to the Registrant’s Registration Statement on Form S-11 (File No. 333-191706) filed on January 20, 2017, and incorporated herein by reference).
4.5 |  | Fourth Amended and Restated Distribution Reinvestment Plan (included as Appendix A in the prospectus that is part of the Registrant's Registration Statement on Form S-3 (File No. 333-220940), filed on December 6, 2017, and incorporated herein by reference).
4.6 |  | Form of Multi-Product Subscription Agreement (included as Appendix F to the prospectus, incorporated by reference to the Registrant's final prospectus filed pursuant to Rule 424(b)(3), filed on February 10, 2017 (File No. 333-191706)).
4.7 |  | Description of Capital Stock Registered Under Section 12 of the Securities Exchange Act of 1934, as amended (included as Exhibit 4.7 to the Registrant's Annual Report on Form 10-K (File No. 000-55435) filed on March 27, 2020, and incorporated herein by reference).

Table of Contents

31.1* |  | Certification of Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2* |  | Certification of Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1** |  | Certification of Chief Executive Officer of the Company, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2** |  | Certification of Chief Financial Officer of the Company, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS* |  | XBRL Instance Document
101.SCH* |  | Inline XBRL Taxonomy Extension Schema Document
101.CAL* |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF* |  | Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB* |  | Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE* |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document
104* |  | Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101).

* | Filed herewith.
** | Furnished herewith in accordance with Item 601(b)(32) of Regulation S-K, this Exhibit is not deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section. Such certifications will not be deemed incorporated by reference into any filing under the Securities Act, except to the extent that the registrant specifically incorporates it by reference.

SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

|  |  | SILA REALTY TRUST, INC.
|  |  | (Registrant)
Date: November 10, 2022 |  | By: | /s/ MICHAEL A. SETON
|  |  | Michael A. Seton
|  |  | Chief Executive Officer
|  |  | (Principal Executive Officer)
Date: November 10, 2022 |  | By: | /s/ KAY C. NEELY
|  |  | Kay C. Neely
|  |  | Chief Financial Officer
|  |  | (Principal Financial Officer and Principal Accounting Officer)